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Enteroviruses (genus Enterovirus, family Picornaviridae) are single-stranded 
RNA viruses associated with a wide variety of diseases. A large number of 
novel enterovirus types have been characterised during the past decade, 
raising a question about the origin of the new viruses. 
In this thesis, genetic evidence for the classification of three new entero-
virus types, enterovirus 94 (EV-94), EV-96 and EV-97, was presented. Further 
characterisation of prevalence and cell tropism was conducted for one of the 
new types, EV-94. Sequence analysis methods were used to infer evolutionary 
relationships between the new and previously known EV types and possible 
mechanisms behind the emergence of new enteroviruses.
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Abstract 
Teemu Smura. The Evolution of New Enterovirus Types EV-94, EV-96 and EV-
97. National Institute for Health and Welfare (THL). Research 87. 160 pages. 
Helsinki, Finland 2012. 
ISBN 978-952-245-700-4 (printed); ISBN 978-952-245-701-1 (pdf) 
 
Enteroviruses (genus Enterovirus, family Picornaviridae) are small single-
stranded RNA viruses associated with a wide variety of acute and chronic dis-
eases. The genus Enterovirus consists of ten species. Seven of the species, Human 
enterovirus A (HEV-A), HEV-B, HEV-C, HEV-D, Human rhinovirus A (HRV-
A), HRV-B and HRV-C, cause infections in humans. The enterovirus species are 
further classified into serotypes (or types) by their antigenic properties and/or, 
more recently, their sequence similarities. 
In this thesis, the genetic evidence for the classification of three new entero-
virus types, enterovirus 94 (EV-94), EV-96 and EV-97, was presented. Further 
characterisation of prevalence and cell tropism was conducted for one of the new 
types, EV-94. Sequence analysis methods were used to infer evolutionary relation-
ships between the new and previously known EV types and possible mechanisms 
behind the emergence of new enterovirus clades. 
The enterovirus strains characterized in this thesis formed distinct monophy-
letic clades within the species HEV-B, HEV-C and HEV-D on the basis of their 
capsid-coding regions. These strains had less than 75% nucleotide (< 85% amino 
acid) sequence similarities with previously known enteroviruses in their VP1 pro-
tein coding sequences, suggesting that these strains represent previously unknown 
enterovirus types, designated as EV-94 (HEV-D), EV-96 (HEV-C) and EV-97 
(HEV-B). The complete genome analysis of the EV-96 and EV-97 strains together 
with the previously characterised HEV-C and HEV-B strains suggested multiple 
inter-typic recombination events within non-coding and non-structural protein-
coding regions of their genomes. No evidence of recombination was detected for 
EV-94 and other members of the HEV-D species. Furthermore, an apparently rare 
inter-species recombination event between the recently described HEV-A types 
(EV-90 and EV-91) and a member of the HEV-C/-D species was found at 5’ un-
translated region (5’UTR) of the genome. 
EV-94 had unusually wide cell type and host species tropism in vitro and, des-
pite recent discovery, a high prevalence of antibodies against EV-94 was detected 
among the Finnish population during the past three decades. These results indicate 
that this virus is highly prevalent and capable of invading a wide variety of tissues. 
The sequence analysis presented in this thesis suggested different evolutionary 
patterns within enterovirus types (leading to intra-typic lineages) and evolution 
leading to larger scale (type-specific) differences. Intra-typic genetic change was 
dominated by silent mutations and amino acid polymorphism at immunogenic 
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sites. Inter-typic comparisons, however, suggested type-specific fixation of amino 
acids and differences in the location of polymorphic amino acid sites between EV 
types. These changes were proposed to be accompanied by structural alterations in 
the capsid proteins, possibly as a result of adaptation to larger scale changes in the 
environment. 
 
Keywords: enterovirus, evolution, recombination, selection, adaptation, Human 
enterovirus A, Human enterovirus B, Human enterovirus C, Human enterovirus D, 
coxsackievirus, echovirus, enterovirus 94, enterovirus 96, enterovirus 97. 
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Tiivistelmä 
Teemu Smura. Evolution of New Enterovirus Types EV-94, EV-96 and EV-97 
[Uusien enterovirustyyppien EV-94, EV-96 ja EV-97 evoluutio]. Terveyden ja 
hyvinvoinnin laitos (THL). Tutkimus 87. 160 sivua. Helsinki, Finland 2012. 
ISBN 978-952-245-700-4 (painettu); ISBN 978-952-245-701-1 (pdf) 
 
Pikornavirusten heimoon kuuluvat enterovirukset ovat pieniä vaipattomia RNA-
viruksia. Enterovirukset aiheuttavat monia akuutteja ja kroonisia tauteja. Enterovi-
rus-suvussa on kymmenen lajia, joista seitsemän Human enterovirus A (HEV-A), 
HEV-B, HEV-C, HEV-D, Human rhinovirus A (HRV-A), HRV-B ja HRV-C 
aiheuttaa infektioita ihmisessä. Enterovirus lajit jaotellaan serotyypeiksi (tai tyy-
peiksi) niiden antigeenisten ominaisuuksien ja nykyisin myös perimän samankal-
taisuuden perusteella. 
Tässä väitöskirjassa tunnistettiin ja luokiteltiin kolme aiemmin tuntematonta 
enterovirustyyppiä, enterovirus 94 (EV-94), EV-96 ja EV-97, perimän nukleotidi-
järjestyksen perusteella. Uusien enterovirusryhmien mahdollista syntytapaa ja 
enterovirustyyppien välistä kehityshistoriaa tutkittiin vertailemalla virusten nuk-
leotidi- ja aminohappojärjestyksiä. Yhden uuden enterovirustyypin (EV-94) esiin-
tyvyyttä ja soluhakuisuutta tutkittiin tarkemmin. 
Väitöskirjassa tunnistetut virukset kuuluivat nukleotidi- ja aminohappojärjes-
tyksensä perusteella HEV-B, HEV-C ja HEV-D lajeihin. Niiden VP1 kuoriproteii-
nia koodaavat nukleotidisekvenssit olivat alle 75 % ja vastaavat aminohappojärjes-
tykset alle 85 % samankaltaisia aikaisemmin tunnettuihin enterovirustyyppeihin 
verrattuna. Tämän perusteella virukset luokiteltiin uusiksi enterovirustyypeiksi ja 
nimettiin EV-94:ksi (HEV-D), EV-96:ksi (HEV-C) ja EV-97:ksi (HEV-B). EV-96 
ja EV-97 kantojen genomeissa havaittiin merkkejä useista enterovirustyyppien 
välisistä rekombinaatioista. EV-94:llä ja muilla HEV-D lajin viruksilla rekombi-
naatiota ei havaittu. HEV-A lajiin kuuluvilla EV-90 ja EV-91 tyypeillä havaittiin 
harvinainen lajien välinen rekombinaatio genomin 5’ päässä. 
EV-94:llä havaittiin muihin enteroviruksiin verrattuna poikkeuksellisen laaja 
kyky infektoida erilaisia solutyyppejä in vitro. Vasta-aineita EV-94:lle löydettiin 
lähes 80 %:sta kolmen vuosikymmenen aikana kerätyistä seeruminäytteistä. Näi-
den tulosten perusteella EV-94 on yleinen virustyyppi, joka pystyy lisääntymään 
monentyyppisissä kudoksissa. 
Sekvenssianalyysin perusteella enterovirustyypin sisällä tapahtuva evoluutio 
on erilaista kuin eri virustyyppien kehittymiseen johtanut evoluutio. Enterovirus-
tyypin sisällä tapahtuu enimmäkseen mutaatioita, jotka eivät johda aminohappo-
muutoksiin. Aminohappojärjestykseen vaikuttavia mutaatiota tapahtuu ainoastaan 
tietyissä, todennäköisesti antigeenisissa, kohdissa. Eri virustyyppien kehittyminen 
on puolestaan johtanut tiettyjen aminohappojen fiksoitumiseen erilaisiksi eri ente-
rovirustyypeissä sekä polymorfisten aminohappoalueitten erilaiseen sijoittumiseen 
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eri virustyypeillä. Tällaiset muutokset saattavat johtua viruksen sopeutumisesta 
erilaisiin ympäristöihin ja ovat todennäköisesti myös johtaneet viruksen kapsidi-
proteiinien rakenteellisiin muutoksiin. 
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Abbreviations 
A adenine 
aa amino acid 
AFP acute flaccid paralysis 
AHC acute haemorrhagic conjunctivitis 
ARI acute respiratory infection 
C cytosine 
Ca2+ calsium 
CD cluster of differentiation 
CPE cytopathic effect 
cre cis-acting replication element 
CVA Coxsackievirus A 
CVB Coxsackievirus B 
DAF decay-accelerating factor 
E echovirus 
eIF eukaryotic initiation factor 
EV enterovirus 
FBS fetal bovine serum 
G guanine 
HCAR human Coxsackievirus and adenovirus receptor 
HEV human enterovirus 
HMFD hand-foot-mouth disease 
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HRV human rhinovirus 
ICAM intercellular adhesion molecule 
IRES internal ribosomal entry site 
ITAF IRES trans-activating factor 
La lupus autoantigen 
nt nucleotide 
ORF open reading frame 
PABP poly(A)-binding protein 
PCBP2 poly(rC)binding protein 2 
p.i. post infection 
PTB polypyrimidine tract-binding protein 
PV poliovirus 
PVR poliovirus receptor 
RdRp RNA dependent RNA-polymerase 
RES reticuloendothelial system 
RNA ribonucleic acid 
SVDV swine vesicular disease virus 
T thymine 
TCID50 50 % tissue culture infectious dose 
Unr upstream of N-ras protein 
UTR untranslated region 
Vpg viral protein genome-linked 
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1 Introduction 
Enteroviruses (genus Enterovirus, family Picornaviridae) are small positive-
stranded RNA viruses with icosahedral capsid structure. The genus Enterovirus 
consists of ten species. Seven of the species, Human enterovirus A (HEV-A), 
HEV-B, HEV-C, HEV-D, Human rhinovirus A (HRV-A), HRV-B and HRV-C, 
cause infections in humans. All of the enterovirus species are further classified to 
serotypes (or types) by their antigenic properties and/or, more recently, their se-
quence similarities. In this thesis, a vernacular term ‘enterovirus’ is used for the 
members of the HEV-A, -B, -C and -D species, whereas the term ‘genus Entero-
virus’ refers to the members of all four HEV species and three HRV species. 
Enteroviruses are among the most common viruses worldwide. Although a 
large majority of enterovirus infections are asymptomatic, these infections are 
known to induce a wide variety of diseases, both acute and chronic. Enteroviruses 
use faecal-oral and respiratory routes of transmission, and the primary replication 
site is in the mucosa of the respiratory or gastro-intestinal tracts. Occasionally, the 
virus may spread via the lymphatic system and circulation to secondary targets, 
including the central nervous system, heart and pancreas. 
To prevent diseases stemming from virus infections, the epidemiology (dy-
namic distribution patterns) and pathogenesis (disease-causing mechanisms) of 
virus infections need to be understood. Evolutionary studies provide the keys for 
understanding both of these areas. RNA viruses have the capacity to evolve ex-
tremely fast due to their short generation times and high mutation rates. These 
characteristics provide the viruses with the ability to adapt rapidly to changes in 
the environment. For example, this rapid adaptation affects virus transmission 
among host populations (e.g., producing mutations resulting in viral epidemics or 
inter-species transmission) and virus distribution within the individual host (e.g., 
producing mutations resulting in changes in cell tropism or course of infection), 
which significantly contribute to the epidemiology and pathogenesis of virus in-
fections. Due to frequent subclinical infections, for most enterovirus types, the 
genetic and phenotypic diversity, epidemiology and association with diseases are 
known only fragmentarily. Likewise, despite years of intensive research, the fac-
tors determining the pathogenesis of enterovirus infections remain enigmatic. This 
thesis addresses several important aspects of enterovirus biology, including se-
quence diversity, evolutionary patterns and viral cell tropism - a consequence of 
sequence diversity and evolution. 
? 
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2 Review of the Literature 
2.1 Enterovirus structure 
The three dimensional structure of several enterovirus types has been determined, 
including poliovirus 1 (PV-1) (Hogle et al., 1985), PV-3 (Filman et al., 1989), 
echovirus 1 (E-1) (Filman et al., 1998), E-7 (He et al., 2002, Plevka et al., 2010), 
E-11 (Stuart et al., 2002), coxsackievirus A9 (CVA-9) (Hendry et al., 1999) cox-
sackievirus B 3 (CVB-3) (Muckelbauer et al., 1995), swine vesicular disease virus 
(SVDV - a lineage of CBV-5) (Fry et al., 2003, Verdaguer et al., 2003) and en-
terovirus 71 (EV-71) (Plevka et al., 2012). All of these enterovirus types show 
strikingly similar features. 
The external diameter of EV particles is approximately 30 nm. The capsid of 
the virus is composed of 60 protomers that form an icosahedral lattice with five-
fold and three-fold symmetry axes (Fig. 1c). Each protomer contains one copy of 
the viral capsid proteins VP1-VP4, which share a common wedge-like shape com-
posed of a β-barrel structure with eight beta strands (named B to F) that form two 
antiparallel (BIDG and CHEF) β-sheets (Fig. 1b). The narrow ends of the VP1 β-
barrels cluster around the five-fold axes of viral particle and the narrow ends of 
VP2 and VP3 β-barrels alternate around the three-fold axes of the viral particle 
(Filman et al., 1989). VP4 and the amino (N-) termini of VP1, VP2 and VP3 are 
inside the capsid and contribute to the stability of the virion via a network of pro-
tein-protein contacts. The C-termini and connecting loops between  the β -sheets 
of VP1, VP2 and VP3 are at the surface of the virion. 
The distinctive features of the capsid surface include a star-shaped plateau at 
the five-fold axes of symmetry with a depression (‘canyon’) around the axes, a 
three-bladed propeller-like structure at the three-fold axes of symmetry and a de-
pression that crosses the two-fold axes (Rossmann et al., 1985) (Fig. 1a). Some but 
not all virus-receptor interaction sites are located at the canyon (Belnap et al., 
2000, Stuart et al., 2002,  Xiao et al., 2005, Zhang et al., 2008). 
Review of the Literature 
 
THL — Research 87/2012 19 Evolution of New Enterovirus Types EV-94, EV-96 and EV-97 
 
 
Figure 1. The structure of the enterovirus capsid (modified from Carrillo-Tripp et 
al., 2009, Filman et al., 1989). (a) The surface of the PV-1-Mahoney cap-
sid. (b) A ribbon diagram that represents the PV-1-Mahoney protomer 
structure. VP1 is shown in blue, VP2 in green, VP3 in red and VP4 in yel-
low. (c) A schematic representation of the icosahedral capsid structure. 
2.2 Enterovirus genome 
The enterovirus genome contains approximately 7500 nucleotides. The genome 
has a single open reading frame (ORF) flanked by 5’ and 3’ untranslated (or non-
coding) regions (UTR or NCR) and a poly(A) tail (Kitamura et al., 1981) (Fig. 2). 
The genome is covalently linked to the VPg protein at the 5’ end. The non-coding 
regions of the genome contain secondary structures essential for replication and 
translation. The ‘clover-leaf’ structure at the 5’UTR (Andino et al., 1990, Andino 
et al., 1993, Rohll et al., 1994) and the stem-loop structures at the 3’UTR (Jacob-
son et al., 1993, Melchers et al., 1997, Mirmomeni et al., 1997, Pilipenko et al., 
1992, Pilipenko et al., 1996) are required for viral replication and a highly ordered 
internal ribosomal entry site (IRES) structure at the 5’UTR is required for the 
initiation of translation (Chen & Sarnow, 1995, Molla et al., 1992, Pelletier & 
Sonenberg, 1988). 
The ORF is translated into single polypeptide that is subsequently self-cleaved 
by viral proteases (reviewed in Palmenberg, 1990) (Fig. 2). The coding sequence 
can be divided into the three regions, P1, P2 and P3, according to the respective 
encoded proteins (see chapter 2.3.2). The coding region also contains cis-acting 
replication element (cre), a secondary structure within the 2C-coding region 
(Cordey et al., 2008, Goodfellow et al., 2000, van Ooij et al., 2006) that is in-
volved in VPg uridylation during genome replication (see chapter 2.3.2) (Paul et 
al., 2000, Rieder et al., 2000). 
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Figure 2. A schematic representation of the enterovirus genome and polyprotein 
processing (modified from De Jesus., 2007). 
2.3 Enterovirus life cycle 
Enterovirus infection begins with the attachment of a virus to a cell surface recep-
tor. This attachment leads to changes in the capsid structure and release of the 
viral genome into the cell. The viral genome is translated by cellular ribosomes to 
single polypeptides that are self-cleaved to yield viral proteins, including viral 
RNA-dependent RNA polymerase, which is a protein required for viral replica-
tion. The replication begins with the synthesis of negative strand RNA that is sub-
sequently used as a template for positive strand RNA synthesis. The positive 
strand genomes assemble with capsid proteins to form mature virions. Finally, the 
cell is lysed, which releases the virions. The complete life cycle of enteroviruses 
typically takes 5 to 10 hours. 
2.3.1 Enterovirus-receptor interaction 
A wide variety of cell attachment receptors have been found for enteroviruses. A 
virus can use a single receptor for attachment and entry or several different recep-
tors and co-receptors during infection (Rossmann et al., 2002). Furthermore, a 
virus may utilise different receptors when infecting different cell types. Different 
viruses may use the same receptor, often with different binding sites (receptor 
footprints). For example, EV-70 uses the decay accelerating factor (DAF, also 
called CD55) in HeLa cells (Karnauchow et al., 1996) and sialic acid-containing 
molecules in leukocytes (Alexander & Dimock., 2002, Haddad et al., 2004, 
Nokhbeh et al., 2005). CVB-3, E-7 and E-12 bind to DAF but with different re-
ceptor footprints (Bergelson et al., 1994, Bergelson et al., 1995, Bergelson et al., 
1997, Bhella et al., 2004, Plevka et al., 2010). 
Review of the Literature 
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After attachment to the receptor the viral capsid must dissociate in order to re-
lease the viral genome into the cell. The uncoating events may differ between 
enteroviruses. For the enterovirus types that have their receptor binding site at the 
viral capsid canyon (e.g., PV, CVB, CVA-21), it has been suggested that the re-
ceptor binding releases a ‘pocket factor’, which is a fatty acid like-ligand that is 
bound to a hydrophobic pocket underneath the canyon floor. This release leads to 
the destabilation of the virus capsid and externalisation of myristoylated VP4 and 
the hydrophobic N-termini of VP1 (Chow et al., 1987, Chow et al., 1987, Crowell 
& Philipson, 1971, Fricks & Hogle, 1990, Huang et al., 2000) that is inserted into 
the cellular membrane (Danthi et al., 2003). These events lead to the formation of 
a pore through which the viral RNA may pass into the cell (Tosteson & Chow, 
1997, Tosteson et al., 2004). The entry mechanisms of enteroviruses are currently 
under intensive research (reviewed in Marsh & Helenius, 2006, Pietiainen et al., 
2005). So far, several putative entry mechanisms have been described (e.g., 
clathrin-dependent and clathrin-independent, lipid raft-dependent and dynamin-
dependent caveolar mechanisms). Furthermore, the entry mechanism may vary 
from one cell type to another (Brandenburg et al., 2007, Coyne et al., 2007). 
2.3.2 Translation 
The viral RNA has to be translated before replication because the host cells lack 
RNA-dependent RNA polymerases (RdRp) required for viral replication, and viral 
enzymes are not brought into the cell by the virus. The virus genome lacks the 5’-
terminal cap structure that is a translation initiation factor assembly site in eukary-
otic cells. Instead, the 5’ non-coding region of the virus genome contains a highly 
conserved secondary structure (internal ribosome entry site (IRES)) that promotes 
translation initiation by internal ribosome binding (reviewed in Bonderoff & 
Lloyd, 2008). 
Picornavirus IRES structures are classified into two major groups: type I (en-
teroviruses and rhinoviruses) and type II (aphtoviruses and cardioviruses). The 
type I IRES (based on PV) contains five stem-loop regions (Fig. 2) (Le & Zuker., 
1990, Pilipenko et al., 1989, Poyry et al., 1992, Rivera et al., 1988, Skinner et al., 
1989). The recruitment and binding of the ribosomal subunits to the IRES is medi-
ated by several canonical translation initiation factors that are also used by cellular 
cap-dependent translation machinery, and non-canonical translation factors that 
are not involved in eukaryotic cap-dependent translation (IRES trans-activating 
factors (ITAFs)). For poliovirus, the canonical translation factors include eukary-
otic initiation factor 4 (eIF4) family members, eIF1, eIF1a, eIF5 and eIF5b, and 
the non-canonical translation factors include polypyrimidine tract-binding protein 
(PTB), poly(rC)binding protein 2 (PCBP2), upstream of N-ras (Unr) and lupus 
autoantigen (La) (reviewed in Bonderoff & Lloyd, 2008). ITAFs may stabilise the 
structure of the IRES to a conformation that is suitable for the binding of canoni-
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cal translation factors and ribosomal subunits (Pilipenko et al., 2000). In addition 
to the 5’UTR binding proteins, the 3’UTR poly(A)-binding protein (PABP) en-
hances IRES-mediated translation (Imataka et al., 1998) via inter-actions with the 
IRES binding translation initiation factors. 
The open reading frame of the enterovirus genome is translated to a single 
polyprotein of ~250 kDa. During translation, the polyprotein is self-cleaved (in 
cis) by viral proteinase 2A to form P1 and proteinase 3C to form P2 and P3 (Fig. 
2). The primary cleavage is followed by a secondary cleavage (in cis or trans) to 
form mature proteins (reviewed in Sean & Semler, 2008). P1 contains viral capsid 
proteins (VP4-VP1), whereas P2 and P3 contain non-structural proteins involved 
in protein processing, shut-off of host cell translation, host cell membrane rear-
rangement and RNA replication. 
Because IRES-mediated translation is intrinsically less efficient than cap-
dependent translation, the virus has to inhibit host translation to ensure that the 
viral RNA does not have to compete with the host mRNA for translation initiation 
factors. This so-called host shut-off is mediated by the cleavage of a subset of 
translation initiation factors. Viral 2A proteinase cleaves eIF4GI (Zamora et al., 
2002) and eIFGII (Gradi et al., 1998), and 2A and 3C proteinases cleave PABP 
(Joachims et al., 1999, Kerekatte et al., 1999, Kuyumcu-Martinez et al., 2004), 
thereby inhibiting cellular (cap-dependent) translation but enhancing viral IRES-
mediated translation (through an unknown mechanism) (Hambidge & Sarnow, 
1992). 
Eventually, viral translation has to be inhibited to use the viral genome as a 
template for replication. The accumulation of viral non-structural proteins may 
induce the transition from viral translation to replication. This transition may oc-
cur by the binding of viral 3CD protein to the clover-leaf, thereby increasing the 
affinity of PCBP2 for this element and decreasing the availability of PCBP2 for 
IRES-mediated translation (Gamarnik & Andino., 2000). Several ITAFs are also 
cleaved by viral 3C proteinase, which results in the inhibition of viral translation 
(Back et al., 2002, Perera et al., 2007). 
2.3.3 Replication 
Following the translation of the viral genome, the enterovirus RNA is translocated 
to the membranous vesicles, where the synthesis of negative and positive strands 
occurs. The mechanism of translocation is not known, but it may involve viral 
3AB and 2C proteins. 3AB has been shown to interact with membranous vesicles 
and viral proteins involved in replication (Towner et al., 1996), whereas 2C has 
been shown to interact with membranous vesicles and negative-stranded RNA 
(Banerjee et al., 1997, Echeverri & Dasgupta, 1995). 
The replication of the enterovirus genome occurs in two steps: first, a negative 
(complementary) strand is synthesised from the parental positive strand RNA, and 
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the negative RNA strand is then used as a template for the synthesis of daughter 
positive strand RNA molecules that can be used for translation or packaged into 
virions (reviewed in Sean & Semler, 2008). 
The initiation of negative strand synthesis involves the interactions of viral and 
cellular proteins in the 3’ and 5’UTRs of the viral genome. A so-called ternary 
complex, composed of PCBP, 3CD and a clover-leaf structure at the 5’UTR of the 
viral genome, circularise the template RNA by binding with PABP in the 3’ 
poly(A), thereby bringing the replication complex to the 3’ poly(A) tract for the 
initiation of negative strand replication (Barton et al., 2001, Bell et al., 1999, Ga-
marnik & Andino, 1997, Herold & Andino, 2001, Parsley et al., 1997). In addition 
to RNA-dependent RNA polymerase 3D, the replication complex contains other 
viral and host macromolecules (including 2C and possibly 3AB, 3CD and 
hnRNPC (Sean & Semler, 2008)). At the 3’ poly(A) tract, the 3D polymerase 
uridylylates the Vpg protein (Paul et al., 1998) and forms VpgpUpU, which is 
used as a primer (complementary to poly(A)) for negative strand synthesis (Flane-
gan & Baltimore, 1977, Yogo & Wimmer, 1973). 
The initiation of positive strand synthesis begins with the recruitment of the 
replication complex containing uridylylated-Vpg to the clover-leaf structure at the 
3’end of the negative-strand RNA (i.e., complementary to the 5’ clover-leaf of the 
positive-strand RNA) (Andino et al., 1990). During the initiation of positive strand 
synthesis, the uridylylation of Vpg occurs on the cre (cis-acting replicative ele-
ment) stem-loop structure at the 2C coding region of viral RNA, where the 3D 
polymerase catalyses the formation of a phosphodiester bond between the tyrosine 
of Vpg and a uridine residue using the adenosine residue of cre as a template (Paul 
et al., 2003). VpgpUpU anneals with the two conserved adenylate residues at the 
3’ end of the negative strand (Sharma et al., 2005). During positive strand RNA 
synthesis, multiple RNA strands are simultaneously synthesised from a negative 
strand template. This simultaneous synthesis is possible, because the hybridisation 
of the nascent positive strand RNA with the negative template RNA is most likely 
inhibited by the extensive secondary structure formation in the positive strand 
RNA or the helicase activity of 3D (Cho et al., 1993) or 3AB (DeStefano & Titi-
lope, 2006). 
2.3.4 Virus assembly and release 
Enterovirus assembly and release apparently do not require host cell components, 
and proceed independently. Following polyprotein cleavage, VP1, VP3 and myris-
toylated immature capsid protein VP0 (consisting of VP4 and VP2) spontaneously 
assemble into protomers and further into pentamers of five protomers. The pen-
tamers assemble into empty capsids that contain 60 copies of each protein. It is not 
known whether the viral RNA is encapsidated by capsid protein pentamers 
(Nugent & Kirkegaard, 1995) or insertion into preformed empty capsids (Jacobson 
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& Baltimore, 1968). Either way, the encapsidation is functionally coupled to RNA 
replication because only newly synthesized virus RNA is packaged to provirion 
(Molla et al., 1991, Nugent et al., 1999). During the encapsidation, VP0 is auto-
catalytically cleaved into VP4 and VP2. This cleavage stabilises the virion and 
increases its infectivity by establishing the ordered N-terminal network of capsid 
proteins (see chapter 2.1). 
The mechanism of virion release from the host cell is not clear. Typically, 
infected cells develop characteristic morphologic changes (including condensation 
of chromatin, nuclear blebbing, proliferation of membranous vesicles, leakage of 
intracellular components, visible rounding and then shrivelling of the cell), which 
is known as the cytopathic effect (CPE) (Racaniello, 2007). The virus-induced 
disruption of Ca2+ homeostasis (by increasing membrane permeability to Ca2+) 
may lead to a cascade that results in a loss of cell membrane integrity, necrosis 
and enhanced virus progeny release (Bozym et al., 2011, van Kuppeveld et al., 
1997). The details of the process, however, most likely depend on the cell type and 
virus strain involved. 
2.4 Pathogenesis of enterovirus infection 
2.4.1 The course of infection 
Enteroviruses are transmitted via the faecal-oral and respiratory routes. The pri-
mary site of infection is at the mucosa of the respiratory or alimentary tracts. Most 
of the human enteroviruses (contrary to human rhinoviruses) are resistant to the 
acidic environment of the stomach and therefore capable of accessing the small 
intestine, where virus replication can continue for several (2-8) weeks. During this 
period, the progeny virus is excreted in the faeces. The cell type where primary 
replication of the virus occurs is not known, but poliovirus might be able cross the 
epithelial barrier via M-cells in Peyer’s patches (Ouzilou et al., 2002, Sicinski et 
al., 1990) and enteroviruses can generally be isolated from the lymphatic tissues of 
the gastrointestinal tract, such as the tonsils, Peyer's patches of the ileum and mes-
enteric lymph nodes (reviewed in Mueller et al., 2005). Despite entering and repli-
cating in the lymphatic tissues, the virus shedding in the intestinal lumen is most 
likely preceded by an infection of the intestinal epithelial cells from the basolateral 
surface (reviewed in Pfeiffer, 2010). 
Focal virus multiplication in the gut mucosa may lead to transient ‘minor’ 
viremia, during which the virus spreads through the lymphatic system and circula-
tion and may lead to virus replication in the reticuloendothelial system (RES), 
which includes phagocytic cells, e.g., mononuclear leukocytes accumulated in the 
lymph nodes and spleen. This replication may amplify the infection to ‘major’ 
viremia and increase the probability of secondary target tissue infection (Freistadt 
& Eberle, 1996). The secondary target tissues vary by enterovirus strain but in-
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clude the central nervous system, meninges, heart and pancreas. Most enterovirus-
related diseases are consequences stemming from the viral infection of secondary 
target tissues. However, in the case of poliovirus, only a fraction of the infected 
individuals develop disease symptoms, and poliomyelitis affects less than 1% of 
PV-infected individuals (reviewed in Mueller et al., 2005). 
2.4.2 Cell and tissue tropism 
Factors affecting enterovirus cell and tissue tropism include receptor specificity, 
the presence of host cell factors required for viral translation and replication, the 
host immune response and the cell-cycle stage of the host cell (reviewed in Whit-
ton et al., 2005). Cell surface receptors are needed for virus attachment, entry and 
(in the case of poliovirus) uncoating. Although required for infection, mere recep-
tor expression does not predict tissue tropism in vivo. For example, poliovirus 
receptor (PVR) is expressed at high levels in the liver, lung and heart, but these 
organs are not thought to be target tissues for poliovirus replication. The viral 
IRES structure appears to be an important tissue tropism determinant for poliovi-
ruses and Coxsackie B viruses (Dunn et al., 2000, Dunn et al., 2003, Evans et al., 
1985, Gromeier et al., 1996, La Monica & Racaniello, 1989, Svitkin et al., 1985), 
which is most likely due to interactions with host cell translation initiation factors, 
the expression levels of which are cell type-specific (Guest et al., 2004, Pilipenko 
et al., 2001, reviewed in Bonderoff & Lloyd, 2008). The host innate immune re-
sponse also contributes to viral cell tropism, because the type I interferon response 
has been shown to restrict poliovirus and coxsackievirus replication in non-target 
tissues (Flodstrom et al., 2002, Ida-Hosonuma et al., 2005). Furthermore, enterovi-
ruses might establish productive infections in cells at the G1/S phases of the cell 
cycle (i.e., during cellular growth and DNA replication) and persistent/latent infec-
tions in quiescent cells (reviewed in Feuer & Whitton, 2008). Highly active cell 
types would therefore be most susceptible to enterovirus infections. 
2.4.3 Diseases 
Although the large majority of the infections are asymptomatic, remarkably di-
verse disease manifestations have been associated with enteroviruses. These dis-
eases include acute (e.g., respiratory tract infections, hand-foot-mouth disease 
(HMFD), acute haemorrhagic conjunctivitis (AHC), aseptic meningitis, encephali-
tis, acute flaccid paralysis (AFP), myocarditis, epidemic pleurodynia, herpangina) 
and chronic (e.g., poliomyelitis, dilated cardiomyopathy, type 1 diabetes, chronic 
fatigue syndrome) diseases (reviewed in Pallansch & Roos, 2001). The disease 
symptoms are generally not specific to a distinct enterovirus type, and several 
different virus types can induce similar disease manifestations. However, a single 
virus type can also cause several different diseases. Knowledge of the pathoge-
netic mechanisms of enteroviruses is incomplete, but direct cellular damage due to 
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lytic virus infection and immunopathogenetic mechanisms (including autoimmu-
nity) has been implicated for many enterovirus-induced diseases. 
The susceptibility to enterovirus infections and enterovirus-induced diseases 
vary by age group and gender. Males are more susceptible than females with male 
to female ratio of 1.2-2.5:1 (reviewed in Pallansch & Roos, 2001). The severity of 
enterovirus-induced diseases is generally considered to correlate with the age of 
the first infection of the given virus type; a delay in the age of the first infection 
increases the risk of more severe symptoms (reviewed in Pallansch & Roos, 
2001). 
2.5 Epidemiology of enterovirus infections 
The epidemiological data for the majority of the enterovirus types are incomplete 
due to apparent pitfalls in the enterovirus surveillance data. Most infections are 
likely to remain unnoticed due to a mild course or lack of disease symptoms. Fur-
thermore, the isolation of a virus from a patient does not prove a causal relation-
ship between the virus and the symptoms. The most reliable data about disease 
incidence with viral etiology can be derived from prospective longitudinal surveil-
lance of a defined population. However, prospective cohort studies are expensive 
and difficult to administrate; therefore, most data about enterovirus-related disease 
incidence are derived from a surveillance of disease cases. Sewage surveillance, 
which is a strategy adopted for poliovirus surveillance in many countries (includ-
ing Finland), provides information about enterovirus prevalence (including asym-
potomatic carriers) in the population (Hovi., 2006) but does not allow inferences 
on disease associations. Therefore, epidemiological data about enteroviruses are 
highly biased due to sampling of certain symptoms (e.g., AFP), generally higher 
sampling frequencies in countries with high socio-economic status (and popula-
tions within the country), increased sampling during epidemics and methodologi-
cal restrictions, such as culturing virus in a limited set of cell lines. 
Despite the obvious biases, some generalisations about the epidemiology of en-
terovirus infections can be made. Enterovirus prevalences vary by species, type, 
geographic location and time. Among healthy children in countries with high so-
cio-economy status, enteroviruses have been detected in approximately 5-15 % of 
stool samples collected during the first few years of life (Gamble., 1962, Patti et 
al., 2000, Simonen-Tikka et al., 2011, Tapia et al., 2011, Witso et al., 2006, Witso 
et al., 2010). Maternal antibodies are thought to protect infants for the first 4-6 
months; after the first year of life, the enterovirus incidence appears to increase 
(Gamble., 1962, Witso et al., 2006, Simonen-Tikka et al., 2012), which coincides 
with the time children are exposed to the infections in kindergarten. Among the 
lower socio-economic populations, the exposure of infants to enteroviruses most 
likely occurs earlier. The highest amount and duration of virus shedding occur 
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during the first infection with a given virus type (because no specific antibodies 
and memory B-cells against this virus type are present). 
Two climatic factors – high degree of humidity and elevated temperatures – 
apparently facilitate EV transmission. Correspondingly, in temperate climates 
enterovirus infections are most prevalent during the summer and early autumn, 
whereas in tropical climates enterovirus circulation tends to be year-round or asso-
ciated with the rainy season (Pallansch & Roos, 2001). 
In temperate climates HEV-B is generally considered to be the most prevalent 
enterovirus species. However, high prevalences of HEV-A types have also been 
reported among healthy children (Simonen-Tikka et al., 2011, Simonen-Tikka et 
al., 2012, Witso et al., 2006) and during certain epidemiological circumstances, 
such as the recent HFMD outbreak (Blomqvist et al., 2010a, Bracho et al., 2011, 
Mirand et al., 2012). It is not known whether the contradictory prevalence reports 
are due to methodological differences in detection sensitivities, biased sampling 
based on disease symptoms or actual changes in the prevalences of the HEV-A 
and HEV-B species over time. The HEV-C strains are rarely detected in temperate 
regions, whereas these strains are highly prevalent in tropical and subtropical re-
gions (Arita et al., 2005, Jegouic et al., 2009, Rakoto-Andrianarivelo et al., 2005, 
Rakoto-Andrianarivelo et al., 2007). HEV-D is considered to be the least prevalent 
of enterovirus species worldwide. However, a high seroprevalence of neutralising 
antibodies against EV-68 and recent reports of EV-68 epidemics suggest that this 
type may be more prevalent than was previously thought (Blomqvist et al., 2002, 
Centers for Disease Control and Prevention (CDC)., 2011, Higgins., 1982, Ikeda 
et al., 2012, Imamura et al., 2011, Jacobson et al., 2012, Kaida et al., 2011, Meijer 
et al., 2012, Oberste et al., 2004, Rahamat-Langendoen et al., 2011, Schieble et al., 
1967, Tokarz et al., 2011, IV). EV-68 is a respiratory pathogen (Oberste et al., 
2004, Schieble et al., 1967) and the lack of detection has most likely been due to a 
sampling bias. Another HEV-D type, EV-70, was first detected in Ghana in 1969 
(Mirkovic et al., 1973) and has since caused two acute haemorrhagic conjunctivitis 
pandemics (Kew et al., 1983, Kono., 1975, Palacios & Oberste, 2005) and several 
smaller scale epidemics (Bern et al., 1992, Gogate., 1997, Maitreyi et al., 1999, 
Shulman et al., 1997). However, no reports of EV-70 detection from the past de-
cade exist, which suggests a low prevalence of this virus at the moment. 
An enterovirus type may have an epidemic or endemic circulation pattern. Epi-
demic virus types (e.g., E-9, E-11, E-30 (Khetsuriani et al., 2006, Oberste et al., 
2003, Savolainen et al., 2001)) show incidence peaks at certain years followed by 
periods of lower prevalence, whereas endemic virus types (e.g., CVA-9, CVB-2, 
CVB-4 (Khetsuriani et al., 2006, Mulders et al., 2000, Santti et al., 2000)) are 
typically isolated every year with little variation in the numbers of isolated strains. 
However, large scale epidemics from endemic virus types may occur occasionally, 
and lineages of epidemic virus types may circulate silently in a distinct geographi-
Review of the Literature 
 
THL — Research 87/2012 28 Evolution of New Enterovirus Types EV-94, EV-96 and EV-97 
 
cal region for several years before causing an outbreak (Savolainen-Kopra et al., 
2011, Tee et al., 2010). Furthermore, outbreaks may occur over large (e.g., E-30 
and EV-71) or restricted (e.g., E-9) geographical areas, over short periods (E-9) or 
several years (E-11) and have a regular cyclic temporal pattern (E-9, E-30, EV-71) 
or irregular periods of quiescence (E-11). The epidemiological pattern of a virus 
type may also depend on the climate. Some of the enterovirus types that are epi-
demic in temperate climates are considered to be endemic in warmer climates 
(Apostol et al., 2012, Bahri et al., 2005). The lineages of some of the epidemic 
enterovirus types, such as E-30 (Bailly et al., 2009, Ke et al., 2011, Mirand et al., 
2007, Oberste et al., 1999b, Palacios et al., 2002, Savolainen et al., 2001, 
Savolainen-Kopra et al., 2011), E-11 (Bouslama et al., 2007a, Savolainen-Kopra 
et al., 2009b) and EV-71 (Tee et al., 2010) have a ladder-like, chronological, 
phylogenetic structure that reflects emergence followed by extinction or dormancy 
and possible re-emergence of dominant lineages. Several lineages may also co-
circulate during an outbreak (Leveque et al., 2010, McWilliam Leitch et al., 2010, 
Oberste et al., 2003, Savolainen-Kopra et al., 2009b). 
2.6 Enterovirus evolution 
Three mechanisms – mutation, recombination and, in the case of viruses with a 
segmented genome, reassortment – produce variation in RNA virus populations 
(reviewed in Domingo et al., 1996, Savolainen-Kopra & Blomqvist, 2010). Point 
mutations are minimal changes in the genome sequence. These mutations may 
occasionally have a profound effect on the phenotype. Recombination and reas-
sortment, on the other hand, segregate RNA fragments between viruses, which 
transfers larger segments of genetic information. Therefore, mutation generates 
variation whereas recombination and reassortment shuffle this variation, produc-
ing new combinations of previously generated mutations. 
Irrespective of the mechanism by which the variant genomes were produced, 
these genomes are subjected to genetic drift and natural selection that ultimately 
define whether a given mutation becomes fixed or eliminated or the corresponding 
position remains polymorphic in the population. Genetic drift is random change in 
the relative frequencies of gene variants (alleles) in the population. Genetic drift 
may have a strong effect on evolution, especially if the population size is very 
small on occasion. During the infectious cycle, enteroviruses are expected to go 
through several genetic bottle-neck events, where the virus population size de-
creases to a small fraction of the original, suggesting that random genetic drift 
may have a profound effect on the genetic structure of enterovirus populations. 
Selection, on the other hand, is a directional force driving evolution. Selection acts 
on mutations that change the fitness of an organism. Positive selection increases 
the frequency of advantageous gene variants, whereas deleterious (harmful) muta-
tions encounter negative (purifying) selection that decreases their frequency. 
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2.6.1 Mutation – Causes and Consequences 
Point mutations are introduced into the enterovirus genome primarily by errors 
made by the viral polymerase during replication and possibly by additional 
mechanisms such as mechanisms that involve host cell deaminating enzymes (re-
viewed in Duffy et al., 2008). The RNA polymerases of RNA viruses have gener-
ally very low fidelity and introduce mutations at a rate of 10-5 to 10-3 substitutions 
per nucleotide per replication event (Drake., 1993, Drake & Holland, 1999, Duffy 
et al., 2008, Holland et al., 1982). The limited replication fidelity of RNA-
dependent RNA polymerase is due to the absence of a proof-reading/repair 
mechanism and postreplicative error correction mechanism. Secondary structures 
in the virus genome can further increase the error-frequency by increasing the 
chance of template slippage during replication (Pathak & Temin, 1992, Pita et al., 
2007). As a result of high mutation frequency, enteroviruses form highly poly-
morphic populations (i.e., quasispecies) where most viral genomes differ from 
each other by one or more nucleotides. 
A high mutation frequency has both harmful and beneficial consequences to 
viruses. Because all organisms are products of natural selection, most random non-
synonymous mutations are likely to decrease the fitness of an organism. Asexually 
reproducing organisms with error-prone replication can therefore be expected to 
incorporate fitness-decreasing mutations into their genomes, unless compensatory 
mechanisms such as back mutation or recombination can restore the state of the 
genome (Muller, 1964). This phenomenon is known as ‘Muller’s ratchet’. Viruses 
with a small population size and high mutation rate are most likely affected by this 
mechanism. Thus, extremely heterogenic RNA virus populations are likely to 
contain genomes with fitness-decreasing mutations (Domingo et al., 1978). 
The high mutation frequency is most likely beneficial when the virus needs to 
adapt to an environmental change or new environment. Due to a high mutation 
rate, a viral population contains a reservoir of potentially useful (pre-adapted) 
variants. Furthermore, the high mutation frequency provides a virus with the 
ability to efficiently explore the changing adaptive landscape (with local peaks of 
high fitness and valleys of low fitness). 
Furthermore, the replication fidelity of a polymerase is also likely to be under 
selection pressure. The fidelity of the poliovirus RNA polymerase can be in-
creased by a single amino acid change (Pfeiffer & Kirkegaard, 2003). The in-
creased fidelity has been shown to be associated with a decrease in fitness in vitro 
and a less virulent phenotype in vivo, which is possibly due to slower replication 
and inability to adapt to different tissues (Pfeiffer & Kirkegaard, 2005, Vignuzzi et 
al., 2006). The mutation frequency can therefore be depicted as a trade-off be-
tween the adaptability and stability of (advantageous) genetic features. In static 
environments natural selection can be expected to favour high fidelity polymer-
ases to reduce the frequency of deleterious mutations. However, enteroviruses are 
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likely to encounter several different and constantly changing environments during 
their transmission cycle (such as the host immune system, differences between 
host individuals, different cell types) and thus benefit from rapid adaptability. 
There may also be a trade-off between the speed and fidelity of replication and the 
cost for rapid replication could be increased error frequency (Elena & Sanjuan, 
2005). The enterovirus ‘life style’ of explosive replication causing acute (lytic) 
infections in constantly changing environment could therefore have favoured 
speed and adaptability at the expense of the replication fidelity. 
The upper limit for the mutation frequency is determined by error threshold. 
Above the error threshold, too many errors accumulate to produce viable offspring 
or to pass genetic information to the next generation. The size of the enterovirus 
genome may be limited by the high mutation frequency, because large genomes 
accumulate more mutations than small genomes (Duffy et al., 2008). At extremely 
high mutation frequencies (i.e., frequencies close to error threshold), RNA viruses 
have been suggested to follow quasispecies population dynamics (Domingo et al., 
2008). According to the quasispecies model, because the high mutation frequency 
prohibits the accurate passing of genetic information to the progeny, the viruses 
form a cloud of related genotypes that constantly mutate to one another (i.e., indi-
vidual viral genomes are linked by a mutational coupling). The replication success 
of a genotype would not depend only on its own replication success but on the 
success of the whole quasispecies cloud around it. Thus, natural selection would 
act on the entire quasispecies population rather than on individual genomes and 
the whole population would evolve as a single unit. 
Due to high mutation frequency, a mutational robustness (the ability to retain 
constant phenotype despite genotypic change) may be favoured instead of high 
fitness. In an extreme case, a population with low fitness but high robustness may 
outcompete a population with high fitness but low robustness (i.e., a population 
occupying a high but narrow peak in the adaptive landscape) (Bull et al., 2005, 
Burch & Chao, 2000, Codoner et al., 2006, Wilke et al., 2001). Therefore, another 
way to compensate for a high mutation rate might be to occupy the flat regions of 
the fitness landscape (with possibility to mutational robustness) instead of the 
narrow fitness peaks (where random mutations are highly likely to cause a drastic 
decrease in fitness) (Codoner et al., 2006, Elena & Sanjuan, 2005, Sanjuan et al., 
2007). Although experimental evidence shows that RNA viruses follow the 
quasispecies dynamics in certain conditions (Burch & Chao, 2000, Codoner et al., 
2006), it has been debated whether the quasispecies dynamics occur in viruses in 
nature, where conditions may not be present in which the quasispecies theory is 
applicable (Holmes & Moya, 2002, Holmes, 2010, Jenkins et al., 2001). 
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2.6.2 Recombination 
Genetic recombination is a widespread phenomenon among enteroviruses (re-
viewed in Lukashev, 2005). During recombination, a ‘donor’ nucleotide sequence 
is introduced into an ‘acceptor’ RNA molecule. Recombination produces a new 
chimeric RNA that contains genetic information from at least two different sour-
ces. Enteroviruses are generally thought to utilise homologous recombination, 
where the donor sequence replaces a homologous region of the acceptor sequence 
and the structure of the molecule is unchanged (Lai, 1992). 
According to strand-switching or copy-choice model (Cooper et al., 1974), the 
viral RNA-dependent RNA polymerase complex switches the template from one 
RNA molecule to another during replication, which forms chimeric RNAs. During 
the negative strand synthesis, secondary structure elements or nucleotide misin-
corporations may slow down and/or stop the RNA polymerase (Pilipenko et al., 
1995, Romanova et al., 1986, Tolskaya et al., 1987, White & Morris, 1995). Sub-
sequently, the nascent RNA strain may dissociate from the original template and 
serve as a primer to resume elongation on another template, producing a recombi-
nant genome. This model has robust experimental support (Duggal et al., 1997, 
Jarvis & Kirkegaard, 1992, Kirkegaard & Baltimore, 1986, Nagy & Bujarski, 
1995, Nagy et al., 1998, Simon & Nagy, 1996). The non-replicative model for 
enterovirus recombination suggests a cleavage of RNA occurs, followed by cross-
ligation in a transesterification reaction (Gmyl et al., 1999, Gmyl et al., 2003). 
Because sequence homology is not required for non-replicative recombination, 
this mechanism may promote the horizontal transfer of genetic material between 
distantly related RNA viruses (Gmyl et al., 2003). 
Recombination may provide the rapid adoption and spread of advantageous 
traits or permit the elimination of detrimental mutations (reviewed in Agol, 2006, 
Simon-Loriere & Holmes, 2011, Worobey & Holmes, 1999). There are, however, 
also limitations with the occurrence of recombination. Recombination requires the 
co-infection of a certain cell with two distinct virus strains. Recombination is also 
constrained by sequence dissimilarity between potentially recombining genomes 
(Worobey & Holmes, 1999). Therefore tissue/cell tropism, prevalence and evolu-
tionary relatedness affect the probability of recombination between given virus 
genotypes. 
Among the enteroviruses, intra-typic and inter-typic recombination has been 
detected. Recombination usually occurs only between members of the same en-
terovirus species. Inter-species recombination is a very rare phenomenon that has 
occurred only a few times during enterovirus evolution (Santti et al., 1999, II). 
Recombination appears to occur frequently in the non-structural regions of the 
genome, whereas recombination seems to be less frequent within the capsid cod-
ing region. However, in polioviruses, recombination in the 3’ end of the VP1 cap-
sid protein coding region (Blomqvist et al., 2003, Blomqvist et al., 2010b, Dedep-
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sidis et al., 2008, Liu et al., 2000, Martin et al., 2002) and in the VP2 protein cod-
ing gene (Kyriakopoulou et al., 2006) has been detected. A chimeric strain of 
CBV-4/CBV-3 with a recombination site within VP3 protein coding region has 
also been described (Bouslama et al., 2007b). 
2.7 Enterovirus classification 
An enterovirus species is defined as a polythetic class of phylogenetically related 
serotypes or strains that share a limited range of natural hosts and host cell recep-
tors, a significant degree of compatibility in proteolytic processing, replication, 
encapsidation and genetic recombination, a greater than 70 % amino acid se-
quence identity in P1, 2C and 3CD proteins and a genome (G+C) base compo-
sition that varies no more than 2.5 % (Knowles et al., 2012). According to current 
classification, the genus Enterovirus contains 10 species. Seven of the species, 
Human enterovirus A (HEV-A), HEV-B, HEV-C, HEV-D, Human rhinovirus A 
(HRV-A), HRV-B and HRV-C, are known to infect humans (Fig. 3). The other 
species of the genus infect monkeys (Simian enterovirus A and a yet unclassified 
novel species consisting of types SV-6, EV-103 and EV-108 that were isolated 
from captive simians (Oberste et al., 2002, Oberste et al., 2007, Oberste et al., 
2008)), bovines (Bovine enterovirus) and pigs (Porcine enterovirus B). The genus 
Enterovirus forms the Picornaviridae family together with the genera Aphthovi-
rus, Avihepatovirus, Cardiovirus, Erbovirus, Hepatovirus, Kobuvirus, Parechovi-
rus, Sapelovirus, Senecavirus, Teschovirus and Tremovirus. In addition, several 
unclassified picornaviruses that infect a variety of host species including mammals 
(e.g., human cosavirus and salivirus, seal picornavirus 1, sheep picornavirus 1 and 
bat kobu-like virus), avians (e.g., turdiviruses), reptiles (e.g., tortoise picornavirus 
1) and fishes have been identified (Knowles, 2012). The Picornaviridae family is 
further classified to the order Picornavirales (Le Gall et al., 2008). 
2.7.1 Enterovirus typing 
Human enteroviruses were originally classified by pathogenic properties, which 
resulted in four groups: polioviruses (PV), coxsackieviruses A (CVA) and B 
(CVB) and echoviruses (E). The first clinical descriptions of poliomyelitis were 
made in the 19th century and poliovirus was isolated and proved to be a causative 
agent for poliomyelitis in 1908 by Landsteiner and Popper. Coxsackie A viruses 
were first characterised during a poliomyelitis epidemic in 1948 from the faeces of 
paralysed children. In contrast to polioviruses, which can only infect primates, 
these viruses caused flaccid paralysis in suckling mice (Dalldorf & Sickles., 1948, 
Dalldorf & Sickles., 1949). The first coxsackie B viruses were isolated in 1949 
from aseptic meningitis cases (Melnick et al., 1949) and found to cause spastic 
paralysis and generalised infection of newborn mice. The development of methods 
for virus isolation in cell cultures enabled the detection of viruses that did not 
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replicate in experimental animals. Echoviruses were first isolated from the stools 
of asymptomatic individuals in 1951 (Robbins et al., 1951). These viruses were 
cytolytic in cell cultures but could not infect common experimental animals. 
Echoviruses were later shown to induce multiple diseases in humans. 
Neutralisation tests showed that all of these virus groups consist of several dif-
ferent serotypes (Bodian et al., 1949, Sickles & Dalldorf., 1949). A serotype is 
considered to be an antigenically distinct group of viruses. A strain is considered 
to represent a new serotype, if it is not neutralised to a significant extent by anti-
sera raised against previously characterised viruses and not able to induce signifi-
cant levels of neutralising antibodies against these viruses. 
It was soon discovered that an individual serotype could not be associated with 
a single disease but rather with a wide range of clinical manifestations. Addition-
ally, it was found that a limited number of molecular differences between the 
strains of a given serotype may affect the pathogenicity of the virus in mice, thus 
confusing the classification of serotypes by pathogenic properties. Thereafter, the 
serologically distinct new enterovirus strains were merely numbered in the order 
of their identification (EV-68 to EV-71). Furthermore, when partial genome se-
quencing became available for enterovirus identification, the classification by 
pathogenic properties was not found to correlate with the evolutionary relation-
ships of the virus strains (Hyypia et al., 1997, Poyry et al., 1996). 
Likewise, there are several difficulties in the antigenic typing of enteroviruses. 
The antigenic sites of the circulating viruses are under a constant evolutionary 
selection pressure posed by the host immune system, which results in antigenic 
drift. Thus, some enterovirus strains represent the antigenic continuum within a 
given serotype, which leads to non-reciprocal neutralisation, e.g., the virus isolate 
may be neutralised poorly by the antiserum that neutralises the reference strain, 
but the antiserum made against the isolate may be able to neutralise both the iso-
late and reference virus. These antigenic variants are called the prime strains of a 
serotype. Extensive cross-reactivity was also detected between some serotypes, 
which were later reclassified on a phylogenetic basis (Brown et al., 2003). 
Sequence relationships offer a more robust basis for classification than pheno-
typic characteristics, and recent molecular detection and identification methods 
have surrogated antigenic typing (reviewed in Nasri et al., 2007). Modern classifi-
cation of the enterovirus types is based on sequence variation in the capsid protein 
VP1-coding region. The classification based on this region correlates with the 
classification made using antigenic properties (Oberste et al., 1999, Oberste et al., 
2000). The strains belonging to the same serotype have > 75% nucleotide (nt) and 
> 85% amino acid (aa) sequence similarity of VP1-coding sequences whereas the 
strains of different serotypes have < 70% nt similarity (< 85% aa similarity) 
(Oberste et al., 1999a, Oberste et al., 1999). However, in some cases, additional 
sequence data are needed to clarify the phylogenetic position of a virus strain 
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(Brown et al., 2009). In this thesis, the term ‘type’ or ‘EV-type’ is used instead of 
‘serotype’ to include all of the strains classified by antigenic characteristics or 
sequence similarities. Because of the high frequency of recombination, the mem-
bers of a type are monophyletic (i.e., have a single common ancestor) only in the 
capsid-coding region of the genome; thus the type designation provides informa-
tion about this region only. 
Molecular typing of enteroviruses has several advantages over the traditional 
antigenic typing. In addition to viral diagnostics, molecular typing provides infor-
mation for detailed epidemiological and evolutionary studies. Furthermore, this 
typing has enabled the characterisation of several antigenically untypable entero-
virus strains (reviewed in Smura et al., 2011). In this thesis, sequence data were 
used for the characterisation of three previously unknown enterovirus types and 
the evolutionary processes behind the appearance of these types. 
 
Figure 3. An unrooted phylogenetic tree constructed from VP1 protein-coding 
sequences using representatives of the seven enterovirus species 
capable of infecting humans. The number of currently known types in 
each species is given in parentheses. 
0,1
HEV-B
HEV-C
HRV-A
HRV-C
HRV-B
HEV-A
HEV-D
(22)
(60)
(23)
(4)
(77)
(25)
(49)
  
THL — Research 87/2012 35 Evolution of New Enterovirus Types EV-94, EV-96 and EV-97 
 
 
3 Aims 
 
The general aim of this thesis was to elucidate the processes behind the origin and 
appearance of novel enterovirus types. 
 
The specific aims were the following: 
1. To characterise enterovirus strains detected during enterovirus surveillance, 
which were ‘untypable’ with traditional methods (I-III). 
2. To elucidate evolutionary relationships between the new and previously char-
acterised enterovirus types and to assess the evolutionary patterns among the 
novel serotypes (I-III, V). 
3. To detect experimentally phenotypic traits (e.g., cell tropism) that might affect 
evolution and pathogenetic properties of new enteroviruses (I & IV). 
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4 Material and Methods 
4.1 Cell culture 
 
The cell lines and primary cells used in the study are indicated in Table 1. The cell 
lines were maintained in a culture medium supplemented with 10% foetal bovine 
serum (FBS). The details of isolation and/or maintenance of the primary cells are 
included in the Material and Methods section of the respective original publication 
(IV). 
4.2 Viruses 
The virus strains characterized in the study are shown in Table 2. For the cell tro-
pism assessment of the HEV-D species, EV-94-E210 (characterized in I) and the 
prototype strains EV-68-Fermon and EV-70-J670/71 obtained from the American 
Type Culture Collection (ATCC, Manassas, VA) were used. 
4.3 Experimental and evolutionary analysis 
The experimental and evolutionary analysis methods are summarised in Tables 3 
and 4. The details are included in the Material and Methods sections of the respec-
tive original publications. 
4.4 Dataset collection for evolutionary analysis 
The reference sequences for evolutionary analysis were obtained from GenBank 
(http://www.ncbi.nlm.nih.gov/genbank/) (Benson et al., 2012). For the recombina-
tion analysis of the HEV-C species (see Results section), the complete genome 
sequences of the HEV-C species obtained with the search terms ‘complete ge-
nome’, ‘enterovirus’, ‘coxsackievirus’, ‘echovirus’ and ‘poliovirus’ were included. 
Because the objective of the analysis was to detect inter-typic recombination 
events, the sequences with more than 90 % complete genome similarity to any 
other sequence were removed from the analysis to relieve computational demands. 
For the EV-97 (HEV-B species) recombination analysis, the complete genome 
sequences with close resemblance to the EV-97 strains were retrieved from Gen-
Bank using the BLAST search (Altschul et al., 1990, Johnson et al., 2008). For the 
HEV-C selection analyses, all of the available complete VP1 sequences of EV-96, 
EV-99, CVA-21 and CVA-24 were retrieved from GenBank. The strains with 
identical amino acid sequences were removed from the dataset. 
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Table 1. The cell lines and primary cells used 
Cell line Tissue origin Culture medium Article 
RD Human rhabdomyosarcoma Eagle’s MEM1 I, II, IV 
Hela  Human cervix Eagle’s MEM1 I, II, III 
CACO-2 Human colorectal adenocarcinoma Eagle’s MEM1 I 
A549 Human lung carcinoma Eagle’s MEM1 I 
Hep-2C Human larynx epidermoid carcinoma Eagle’s MEM1 I 
HUH-7 Human hepatocellular carcinoma Eagle’s MEM1 I 
SK-N-SH Human neuroblastoma Eagle’s MEM1 I 
KG-1 Human leukocyte (granulocytic) IMDM2 IV 
HL-60 Human leukocyte (granulocytic) RPMI3 1640 IV 
THP-1 Human leukocyte (monocytic) RPMI3 1640 IV 
U-937 Human leukocyte (monocytic) RPMI3 1640 IV 
RC-2A Human leukocyte (monocytic) RPMI3 1640 IV 
Jurkat Human leukocyte (T-cell) RPMI3 1640 IV 
MOLT Human leukocyte (T-cell) RPMI3 1640 IV 
Raji Human leukocyte (B-cell) RPMI3 1640 IV 
Endothelial Human primary endothelial cells D- MEM1 IV 
Pancreatic islet Human primary pancreatic islets Ham’s F10 IV 
GMK Green monkey kidney Eagle’s MEM1 I, IV 
Vero Green monkey kidney Eagle’s MEM1 I 
3T3 Mouse embryo fibroblast Eagle’s MEM1 I 
BHK21 Hamster kidney Eagle’s MEM1 I 
RK13 Rabbit kidney Eagle’s MEM1 I 
MDCK Canine kidney Eagle’s MEM1 I 
MDBK Bovine kidney Eagle’s MEM1 I 
L20B Mouse fibroblast expressing human 
PVR 
Eagle’s MEM1 I 
CHO-HCAR Chinese hamster ovary cells express-
ing human coxsackievirus and adeno-
virus receptor (HCAR) 
Eagle’s MEM1 I 
M4 Mouse fibroblast expressing ICAM-1 Eagle’s MEM1 I 
1 Minimum essential medium 
2 Iscove’s modified dulbecco’s medium 
3 Roswell Park Memorial Institute medium 
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Table 2. The virus strains characterized 
 
Species Type Strain Country Symp-
toms 
Sample 
type 
Sequence 
region 
Arti-
cle 
HEV-A EV-76 KAZ00-
14550 
Kazakh-
stan 
AFP1 Stool 5’UTR, VP1, 
partial 3D 
II 
HEV-A EV-90 LVA02-
10337 
Latvia Healthy Stool 5’UTR, VP1, 
partial 3D 
II 
HEV-B EV-97 FIN03-
2875 
Finland 
(India) 
Healthy Stool Complete 
genome 
II2 
HEV-C EV-96 SVK03-24 Slovak 
Republic 
AFP1 Stool 5’UTR, VP1, 
partial 3D 
II 
  FIN04-7 Finland 
(Thailand) 
Healthy Stool Complete 
genome 
II, III 
  FIN05-2 Finland 
(China) 
Healthy Stool Complete 
genome 
II, III 
  FIN05-5 Finland 
(China) 
Healthy Stool 5’UTR, VP1, 
partial 3D 
II 
  FIN05-10 Finland 
(China) 
Healthy Stool 5’UTR, VP1, 
partial 3D 
II 
  FIN05-12 Finland 
(China) 
Healthy Stool 5’UTR, VP1, 
partial 3D 
II 
  FIN05-14 Finland 
(China) 
Healthy Stool 5’UTR, VP1, 
partial 3D 
II 
  FIN06-7 Finland 
(China) 
Healthy Stool 5’UTR, VP1, 
partial 3D 
II 
HEV-D EV-68 37-99 France NA Stool Complete 
genome 
I 
 EV-94 E210 Egypt  Sewage Complete 
genome 
I, IV 
  E430 Egypt  Sewage VP1, partial 
3D 
I 
  E435 Egypt  Sewage VP1, partial 
3D 
I 
  E438 Egypt  Sewage VP1, partial 
3D 
I 
  19-04 DRC3 AFP1 Stool Complete 
genome 
I 
1 Acute flaccid paralysis 
2 Complete genome sequence unpublished 
3The Democratic Republic of Congo 
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Table 3. Experimental methods used 
Virological methods  Article 
Virus isolation from stool I, II 
 from sewage I 
Virus purification Plaque purification I, II, IV 
 End-point titration II, III 
Virus culture  I, II, III, IV 
Infectivity assay TCID501 I, II, III, IV 
Growth curve analysis Infection + TCID50 I, IV 
Immunofluorescence 
detection of virus 
In-house enterovirus specific Ab2 +  
Immunofluorescence microscopy 
I, IV 
Ab prevalences Serum neutralization assay I, IV 
Acid sensitivity Acid sensitivity assay I 
Receptor usage CPE3-protection assay I 
Molecular biology methods   
RNA-extraction  I, II, III 
Reverse transcription PCR  I, II, III 
cDNA synthesis  I, II, III 
PCR Primer walking strategy I, II, III 
Sequencing Sanger sequencing I, II, III 
PCR-product purification Agarose gel extraction I, II, III 
Cellular biology methods   
Cell culture  I, II, III, IV 
Primary cell isolation  IV 
Cell viability assays WST (tetrazolium salt) IV 
 Live-Dead (calcein / ethidium homodimer-1) IV 
 Insulin-DNA ratio IV 
Cell detection Immunofluorescence microscopy I, IV 
150 % Tissue culture infectious dose 
2Antibody 
3Cytopathic effect 
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Table 4. Sequence analysis methods used. 
 Method Reference Software 
BLAST blastn (Altschul et al., 
1990) 
NCBI web site1 
Sequence assembly   ContigExpress, Vector NTI 
10.1 
Alignment ClustalW (Thompson et al., 
1994) 
ClustalX v 1.81 2  
MEGA 3.1-5.03 
Substitution model p-distance  MEGA 3.1-5.0 
 Tamura-Nei (Tamura & Nei., 
1993) 
 
 Generalised 
time reversible 
(Tavaré., 1986) Datamonkey4 
Phylogenetic tree 
construction 
Neighbor Joining (Saitou & Nei., 
1987) 
MEGA 3.1-5.0 
 Maximum likeli-
hood 
(Felsenstein., 1981) Tree-Puzzle v 5.25 
Recombination Similarity plot (Lole et al., 1999) Simplot 2.56 
 Bootscanning (Salminen et al., 
1995) 
 
Selection SLAC (Kosakovsky Pond & 
Frost., 2005) 
Datamonkey 
 FEL   
 REL   
 McDonald-
Kreitman test 
(McDonald & Kreit-
man., 1991) 
DnaSP v.5.107 
References for the software used: 
1 (Johnson et al., 2008) 
2 (Thompson et al., 1997) 
3 (Kumar et al., 2004, Tamura et al., 2007, Tamura et al., 2011)  
4 (Delport et al., 2010) 
5 (Schmidt et al., 2002) 
6 (Lole et al., 1999) 
7 (Librado & Rozas., 2009) 
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5 Results 
5.1 Genetic characterisation of the untypable enterovirus 
strains (I, II & III) 
Three new enterovirus types, designated as EV-94, EV-96 and EV-97, were char-
acterised in this thesis. An enterovirus strain is considered to form a new type 
when the strain has < 70 % nucleotide (nt) sequence similarity and < 85 % amino 
acid (aa) sequence similarity in the VP1-coding region with the strains represent-
ing the known enterovirus types and the strains of the proposed new type form a 
monophyletic group in this region (Oberste et al., 1999, Oberste et al., 2000). 
Since the initial isolation, several strains have been characterised for all of the new 
enterovirus types in Finland and elsewhere. 
EV-94 was concurrently isolated from sewage in Egypt (4 strains) and acute 
flaccid paralysis (AFP) patients in the Democratic Republic of the Congo (DRC) 
(2 strains). A BLAST search suggested that EV-94 was related to the strains of the 
HEV-D species. The VP1 nt and aa sequence similarities (Table 5) and the phylo-
genetic analysis of this region (Fig. 4) suggested that the EV-94 strains form a 
novel type in the HEV-D species. 
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Figure 4. A phylogenetic tree constructed from the VP1-coding nt sequences of the 
HEV-D strains. The tree was constructed using the Neighbour-Joining 
method. The reliability of the inferred branching patterns was assessed 
using bootstrap test with 1000 replicates. The bootstrap values > 70 % 
are shown. The genetic distances were computed using the Tamura-Nei 
model for nt substitutions. 
The first EV-96 strain (EV-96-SVK03-24) was isolated from a faecal sample of a 
four year old child with AFP in the Slovak Republic. Subsequently, similar viruses 
were detected from healthy children adopted from Southern Asia to Finland. The 
sequence similarities and phylogenetic analysis based on the VP1-coding region 
suggested that these virus strains form a new type in the HEV-C species (Fig. 5). 
The EV-97 strain FIN03-2875 was isolated in Finland from a faecal sample 
from a healthy 3-year-old child adopted from India. In the phylogenetic analysis, 
this isolate grouped together with the HEV-B serotypes in the VP1 region but had 
only 68.4 % nt and 78.0 % aa sequence similarities with the closest enterovirus 
prototype strain (E-27). These results suggest that this virus strain represents a 
new enterovirus type (Fig. 6). 
Currently, 20 strains of the EV-97 type have been detected, and complete VP1 
sequences are known for 11 of the strains. In the phylogenetic analysis, the EV-97 
strains grouped together with the E-27 strains. The pairwise nt and aa similarities 
between the EV-97 strains were 80.8-99.2 % and 92.0-99.3 %, respectively, and 
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the nt and aa similarities between the EV-97 and E-27 strains were 67.6-71.9 and 
77.2-78.9 %, respectively. The VP1 phylogenetic tree showed a ladder-like struc-
ture, in which a strain isolated from a faecal sample from a 5-year-old boy with 
AFP in 1999 (Tao et al., 2010) formed an outgroup to all other strains. EV-97-
FIN03-2875 clustered with two strains isolated from India and Pakistan. 
Table 5. Nucletide and amino acid sequence differences (%) between EV-94-
E210 and other HEV-D strains 
 Nucleotide sequence Amino acid sequence 
 EV-94 
19-04 
EV-70-
J670/71 
EV- 68-
Fermon 
EV94- 
19-04 
EV 70-
J670/71 
EV 68-
Fermon 
Complete 
genome 
ND 75.8 73.7 97.0 86.9 84.8 
5’ UTR ND 83.5 76.2    
VP 4 85.0 79.7 77.3 97.1 95.7 89.9 
VP 2 86.0 74.8 74.2 98.8 84.4 84.7 
VP 3 84.3 70.9 70.1 99.1 80.4 82.6 
VP 1 86.3 67.8 67.7 97.1 73.6 71.4 
2 A 84.1 73.6 69.6 93.9 85.2 82.3 
2 B 81.5 75.1 76.4 92.9 94.9 85.9 
2 C 83.5 77.8 77.4 96.1 90.0 88.2 
3 A 86.1 78.3 78.3 96.6 92.1 89.9 
3 B 86.4 66.7 75.8 100.0 95.5 86.4 
3 C 84.5 76.3 72.9 96.7 88.0 88.0 
3 D 89.9 82.7 77.0 97.8 95.2 90.6 
3’ UTR ND 80.7 68.8    
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Figure 5. A phylogenetic tree constructed from the VP1-coding nt sequences of the 
EV-96 strains and the prototype strains of the other types of HEV-C spe-
cies. The tree was constructed using the Neighbour-Joining method. The 
reliability of the inferred branching patterns was assessed using a boot-
strap test with 1000 replicates. The bootstrap support values > 70 % are 
shown. The genetic distances were computed using the Tamura-Nei 
model for nt substitutions. 
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Figure 6. A phylogenetic tree constructed from the VP1-coding nt sequences of the 
EV-97 and E-27 strains and the prototype strains of HEV-B using the 
Neighbour-Joining method. The reliability of the tree topology was as-
sessed using a bootstrap test with 1000 replicates. The bootstrap values 
> 70 % are shown. The genetic distances were computed using the Ta-
mura-Nei model for nt substitutions. 
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5.2 Analysis of the complete genome sequences (I, III, V) 
 
For further genetic characterisation and inference of evolutionary relationships and 
mechanisms, the complete genomes of two EV-94 strains, two EV-96 strains and 
one EV-97 strain were sequenced and analysed together with sequences derived 
from GenBank. 
5.2.1 EV-94 in the HEV-D species (I) 
Currently, the complete genome sequences are available for seven strains of the 
HEV-D species. High intra-typic similarities were detected between the two EV-
94 strains and between the EV-68 strains in all regions of the genome (Table 5, 
Fig. 7). The phylogenetic trees constructed from the P1, P2 and P3 regions or the 
partial 3D sequences (more EV-94 strains) were essentially congruent (Fig. 8). 
Furthermore, the bootscanning analysis of the complete genome sequences indi-
cated robust clustering of the EV-94 strains together in all regions of the genome 
(Fig. 7). 
Between the EV-94 strains, approximately equal divergences were detected for 
the P1-, P2- and P3-coding regions of the genome in the nucleotide and amino 
acid sequence comparisons. Whereas for the EV-68 strains, nucleotide diver-
gences were similar for the P1-, P2- and P3-coding regions, but the amino acid 
differences were slightly higher in the P1 region (Table 6). Between serotypes the 
distances were higher for the P1 than the P2 and P3 sequences. Of the distinct 
genes, the sequence divergences were highest in the VP1-coding region. 
Table 6. Ranges of pairwise nucleotide and amino acid sequence divergences 
(%) in HEV-D P1-P3 regions for intratypic and intertypic comparisons 
 Nucleotide sequence divergence (%) 
 P1 P2 P3 
 Intratypic Intertypic Intratypic Intertypic Intratypic Intertypic 
EV-94 14.4 28.4-29.1 16.5 22.6-24.5 11.9 19.7-23.9 
EV-70 ND 28.4-32.0 ND 22.6-26.0 ND 19.7-24.6 
EV-68 0.1-12.6 28.4-32.0 1.2-12.0 23.3-26.0 1.0-11.5 22.9-24.6 
 Amino acid sequence divergence (%) 
EV-94 1.9 18.5-20.9 5.2 10.3-13.0 2.5 6.4-10.3 
EV-70 ND 18.5-23.7 ND 10.3-15.2 ND 6.4-12.0 
EV-68 0.3-6.4 19.6-23.7 0.5-2.5 11.8-15.2 0.4-2.8 9.7-12.0 
Results 
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Figure 7. The similarity plots (a-b) and bootscanning analysis (c) of the complete 
HEV-D genomes. EV-94-E210 (a, c) and EV-68-Fermon (b) were used 
as query sequences. The similarity plot analysis was conducted using a 
sliding window of 200 nt moving in 20 nt steps. The bootscanning analy-
sis was conducted using a sliding window of 500 nt moving in 20 nt 
steps. The genetic distances were computed using the Kimura 2-
parameter model. The Neighbour joining method was used for the tree 
construction. The bootstrap values were calculated for 100 replicates. 
The transition to transversion ratio was estimated for each window. 
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Figure 8. The phylogenetic trees constructed from the P1-, P2-, P3- and partial 3D-
coding nucleotide sequences of the HEV-D strains. The trees were con-
structed using the Neighbour-Joining method. The bootstrap support 
values were calculated for 1000 replicates. The genetic distances were 
computed using the Tamura-Nei method. 
5.2.2 EV-96 in the HEV-C species (II, V) 
The complete genome sequences are known for five EV-96 strains. The similarity 
plot analysis suggested that the nt distances are approximately equal in the P1-, 
P2- and P3-coding regions between the strains FIN05-2, 05517 and 09228C1 (Fig. 
9a). Similarly, the strains FIN04-7 and BAN00-10488 share equal similarities in 
all three regions (Fig. 9b). However, in the P2 and P3 regions the strains FIN04-7 
and BAN00-10488 have low sequence similarity to the other three EV-96 strains. 
The phylogenetic analysis of the EV-96 strains and the prototype strains of the 
other members of the HEV-C species suggested that the EV-96 strains are mono-
phyletic only in the capsid-coding (P1) region (Fig. 1 in III). These results suggest 
that recombination has occurred between EV-96 and other HEV-C types. Recom-
bination was further verified using similarity plot and bootscanning methods (Fig. 
2 in III). The strains EV-96-FIN05-2, EV-96-05517 and EV-96-09228C1 grouped 
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together with CVA-24 and CVA-21 in the non-structural protein P2-coding region 
(Fig. 10b and Fig. 1b in III), whereas this clustering was not well-supported in the 
P3 coding region (Fig. 10c). In the P2 and P3 regions, the strains EV-96-FIN04-7 
and EV-96-BAN00-10488 were clearly related to CVA-1, CVA-19, CVA-22, EV-
104 and EV-109 prototype strains (Fig. 10 and Fig. 1c in III). Two apparent re-
combination sites were detected for the EV-96 strains FIN04-7 and FIN05-2 on 
the 5′ and 3′ ends of the capsid-coding region. The nt and aa sequence alignments 
suggested that the recombination sites might be within the 5’UTR-VP4 and at the 
3′ end of the 2A protein coding regions. 
 
Figure 9. The similarity plots of complete EV-96 genomes using a sliding window 
of 200 nt moving in 20 nt steps. EV-96-FIN05-2 (a) and EV-96-FIN04-7 
(b) were used as query sequences. 
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Figure 10. The phylogenetic trees constructed from the P1- (a), P2- (b) and P3- (c) 
coding nt sequences of the HEV-C strains. The strains that show robust 
(> 70% bootstrap support) incongruent clustering in comparison to the P1 
clustering are indicated with arrows. The open arrows indicate recombi-
nation within the major clusters A, B or C, and the solid arrows indicate 
recombination between the major clusters. The trees were constructed 
using the Neighbour-Joining method. The bootstrap support values were 
calculated for 1000 replicates. The genetic distances were computed 
using the Tamura-Nei model for nt substitutions. 
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To gain further insight into the recombination patterns within the HEV-C species, 
all of the HEV-C complete genome sequences available in GenBank (search 
21.10.2011) were compared. At the P1 region, all of the strains clustered into three 
groups, which are designated as A (CVA-1, -19, -22, EV-104 and EV-109), B 
(EV-96, EV-99, CVA-21 and -24) and C (CVA-11/15, -13/18, -17, -20, EV-102, 
PV-1, -2 and -3) (Fig. 10a), with the branching order of cluster A diverging first 
from the common ancestor of clusters B and C. Within clusters B and C, the 
phylogenetic analysis suggested well-supported hierarchical branching orders. 
Within cluster B, EV-96 forms an outgroup to the CVA-21/CVA-24/EV-99 clus-
ter, suggesting that EV-96 has diverged first from a common ancestor of group B. 
This divergence has been followed by the branching of CVA-21 from the ancestor 
of CVA-24/EV-99 and finally a splitting of the ancestor of CVA-24/EV-99 into 
two distinct types. Within cluster C, CVA-11/15 forms an outgroup to all of the 
other types, which is followed by a separation of the polioviruses from the CVA-
13/18, CVA-17 and closely related EV-102/CVA-20 types. Within the poliovirus 
group, PV-3 appears to have diverged first from the common ancestor, followed 
by the divergence of PV-2 and PV-1. 
At the P2 region, the three major clusters (A-C) remain congruent with two ex-
ceptions: two EV-96 strains group together with cluster A, and the CVA-13/18 
strains group together with EV-99 in cluster B (Fig. 10b). However, within the 
major clusters, the P2 phylogenies are largely incongruent with those of the P1 
region, suggesting promiscuous recombination within clusters A, B and C (in 
contrast to the apparently rare recombination between these clusters). 
At the P3 region, all of the strains from clusters B and C merge into one large 
cluster (B+C), whereas cluster A remains separate from the others (Fig. 10c). Only 
a few P1 clusters remain congruent throughout the genome. Two notable excep-
tions are presented by some CVA-21 strains and CVA-24v (AHC-causing variant) 
strains, which show no traces of recombination. 
Within cluster A, the EV-96 strains (FIN-04-7 and BAN00-10488) form a con-
gruent subcluster throughout the P2 and P3 regions, and, likewise, EV-104 and 
EV-109 form a subcluster in these regions. However, at the P2 region, EV-104 
and EV-109 are closer to CVA-1/-19/-22 than the EV-96 strains, whereas, at the 
P3 region, the EV-96 strains are closer to CVA-1/-19/-22 group. Furthermore, the 
similarity plot analysis suggests a very close relationship between the EV-96 
strains and CVA-1/-19/-22 at the last ~500 nucleotides of the 3’ end of the genome 
(Fig. 2a in III). These results suggest that multiple recombinations within cluster A 
have occurred during the evolutionary history of these strains. 
5.2.3 EV-97 in the HEV-B species (unpublished) 
The complete genomes have been sequenced for four EV-97 strains. The phyloge-
netic analysis of EV-97 and the prototype strains of the HEV-B species showed 
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that the EV-97 strains formed a monophyletic group in the P1 region only (Fig. 
11). In this region, the EV-97 strains and the closest type E-27 form a cluster with 
E-17 and the recently described HEV-B types EV-81, EV-87, EV-88 and EV-98 
(Fig. 11a). In the P2 region, only a few of the prototype strains form well-
supported clusters, and the clusters are almost unanimously incongruent to those 
observed at the P1 region. However, EV-97-FIN03-2875 and EV-97-DT94-0227 
cluster together at P2 (Fig. 11b). In the P3 region, a more robust clustering pattern 
was observed (Fig. 11c). However, the P3-based phylogeny was largely incongru-
ent to that of the P1 region. In the P3 region, the prototype strains formed two 
major clusters, the larger of which contained several subclusters. The strains EV-
97-FIN03-2875, EV-97-BAN99-10355 and EV-97-DT94-0227 grouped together 
with the E-30, EV-74, EV-75, EV-85, EV-86, EV-87, EV-88, EV-98, EV-100 and 
EV-107 prototype strains. The strain EV-97-FIN03-2875 grouped together with 
EV-86, whereas the strains EV-97-BAN99-10355 and EV-97-DT94-0227 were 
phylogenetically close to each another. 
A BLAST search using different genome regions of the EV-97 strains as query 
sequences was conducted to detect possible similarities between the circulating 
HEV-B strains and EV-97 strains in the non-structural protein-coding regions. The 
circulating strains with more than 83 % BLAST search similarity in the P3 region 
clustered together with EV-97-FIN03-2875, EV-97-BAN99-10355 and EV-97-
DT94-0227 (Fig. 11d) and were included in the recombination analysis. At the P2 
region, the EV-97 strains did not show bootstrap-supported clustering with the 
prototype strains, and circulating strains with high similarity were not detected 
with the BLAST search. 
In the similarity plot analysis (Fig. 12a), no close relatives to EV-97-FIN03-
2875 were found within the first 1000 nucleotides of the P2 region (corresponding 
to the nt sites 3300-4500 of the complete genome sequence). There was a sharp 
increase in the sequence similarities between EV-97-FIN03-2875 and EV-97-
DT94-0227 corresponding to nt sites 4500-5200 of the complete genome sequence 
and an overlapping but shorter region of similarity between EV-97-FIN03-2875 
and EV-86-BAN00-1035, CVB-3-MHC and E-30-TW/3182/01. High similarities 
with EV-97-FIN03-2875 were also detected for CVB-5-COXB5/Henan/2010 
corresponding to nt sites 4800-5300 of the complete genome sequence and EV-
100 corresponding to nt sites 5300-5800 of the complete genome sequence. At the 
3’ end of the P3 region that corresponds to nt sites 6000-7400, EV-97-FIN03-2875 
and EV-86-BAN00-1035 showed high sequence similarities, whereas E-30-
1167438/CBV-1-1167438 and E-7-LR11F7 showed high similarity to EV-97- 
FIN03-2875 at shorter regions near the 3’ end of the genome. Bootscanning analy-
sis (Fig. 12b) suggested phylogenetic clustering with the corresponding recombi-
nation partners. 
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Figure 11. The phylogenetic trees constructed from the P1- (a), P2- (b) and P3- (c) 
coding nucleotide sequences of the HEV-B prototype strains and the P3 
region of the HEV-B strains retrieved from GenBank (d). The arrows indi-
cate EV-97 strains. The trees were constructed using the Neighbour-
Joining method. The bootstrap support values were calculated for 1000 
replicates. The genetic distances were computed using the Tamura-Nei 
model for nt substitutions. 
Results 
 
THL — Research 87/2012 59 Evolution of New Enterovirus Types EV-94, EV-96 and EV-97 
 
 
Figure 12. The similarity plot (a) and bootscanning (b) analysis of the HEV-B strains 
that cluster together with EV-97-FIN03-2875 in the P3 region (Fig. 11d). 
The similarity plot analysis was conducted using a sliding window of 200 
nt moving in 20 nt steps with EV-97-FIN03-2875 as a query sequence. 
The bootscanning analysis was conducted using a sliding window of 500 
nt moving in 20 nt steps. The genetic distances were computed with the 
Kimura 2-parameter nucleotide substitution model, and Neighbour-
Joining method was used for the phylogenetic tree construction. The 
bootstrap values were calculated for 100 replicates. The transition to 
transversion ratio (Ts/Tv) was estimated for each window. 
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Out of the three EV-97 strains derived from GenBank, EV-97-DT94-0227 showed 
similarity to E-30-TW/3182/01 and CVB-3-MCH at the 3’ end of the genome 
(5900-7400), whereas EV-97-99188/SD/CHN/1999 showed larger divergences at 
the non-structural region. However, E-9-DM and E-30/Zhejiang/17/03/CSF show 
the closest relation to this strain throughout the P2 and P3 regions (4000-7400). 
Likewise, the similarities between EV-97-BAN99-10355 and the other HEV-B 
strains were less than 90 % throughout the non-structural region. 
5.3 Phylogenetic analysis of the 5’UTR (II) 
The complete genome sequence analyses presented here and in other studies (see 
Chapter 6.3) suggest promiscuous recombination among the HEV-A, HEV-B and 
HEV-C strains. At the protein-coding regions, recombination appears to occur 
exclusively between the strains of the same species. 
In contrast to the coding regions of the enterovirus genome, where all of the 
enterovirus strains cluster into four groups (representing the species HEV-A to –
D), only three clusters were observed in the trees constructed from the 5’UTR 
sequences (Fig. 13). Cluster I is composed of strains from the HEV-C and HEV-D 
species, cluster II is composed of strains from the HEV-A and HEV-B species 
(Hyypia et al., 1997), and cluster III is composed of the HEV-C types EV-104 and 
EV-109 (Tapparel et al., 2009, Yozwiak et al., 2010). 
The incongruity between the clustering patterns of the 5’UTR and other re-
gions of the genome suggests that at least two ancient inter-species recombination 
events and several inter-typic recombination events have occurred within the 
5’UTR during the evolutionary history of the enteroviruses (see Chapter 6.2.2.4). 
In this work (II), the recently discovered HEV-A types EV-90 and EV-91 were 
shown to cluster together with types from the HEV-C and HEV-D species (Fig. 
13b). This clustering strongly suggests that an additional inter-species recombina-
tion event occurred between the ancestor of EV-90/91 and a member of the 5’UTR 
cluster I (i.e., a strain belonging to the HEV-C or HEV-D species) or between EV-
90 or EV-91 and a member of the 5’UTR cluster I followed by an intertypic re-
combination event between EV-90 and EV-91. Two other recently described 
HEV-A types, EV-76 and EV-89, form an outgroup to the 5’UTR cluster II 
(strains of the HEV-A and HEV-B species), whereas EV-68 forms an outgroup to 
the 5’UTR cluster I (strains of HEV-C and HEV-D species). 
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Figure 13. The phylogenetic trees constructed from the 5’UTRs of the strains repre-
senting all of the HEV species (a) and the prototype strains forming clus-
ter I (b). The trees were constructed using the Neighbour-Joining 
method. The bootstrap support values were calculated for 1000 repli-
cates. The genetic distances were computed using the Tamura-Nei 
model. To exclude the possible recombination site, only the first 500 nts 
of the 5’UTR were used. The bootstrap support values are shown only 
for major clusters (a) or clusters with a value > 70 (b). 
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5.4 Evolutionary patterns of the VP1-coding region: EV-96 as 
a model type (II, III, V) 
 
To elucidate mechanisms by which new enterovirus types have originated and 
evolved, the mutation patterns in the VP1 region of EV-96 were studied and com-
pared to closely related EV types. EV-96 was chosen for this analysis, because the 
most sequence data have accumulated from this type compared to the other new 
EV-types described in this thesis. As discussed above, due to frequent recombina-
tion, different regions of the enterovirus genome can be considered to evolve 
semi-independently. Because recombination in the capsid-coding region is rare, 
and molecular typing efforts have provided abundant sequence data for the VP1 
region, the mutation patterns between virus lineages can be reliably assessed using 
this region. 
5.4.1 Sequence diversity and phylogenetic analysis of EV-96 (I) 
A wide variation in the nucleotide and amino acid sequences of the VP1-coding 
region was observed among the EV-96 strains (Table 7). The divergences were as 
high as 75 % at the nt sequence level and 89 % at the aa sequence level, which 
corresponded to 229 (of 927) nt and 33 (of 309) aa substitutions among the EV-96 
strains. 
Table 7. The pairwise nucleotide (lower left) and amino acid (upper right) 
similarities between the EV-96 strains in the VP1-coding region (%). The 
similarities within the intra-typic subclusters are indicated with colours: 
orange (A), green (B1), blue (B2). 
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In the phylogenetic tree, the EV-96 strains form two major clusters (Fig. 14), 
which are designated as A and B. The nucleotide sequence similarities within the 
subclusters were 80.4 % and 78.6-96.3 % (mean 83.6 %; S.E. 0.7) for clusters A 
and B, respectively, and the mean sequence similarity between the subclusters was 
77.8 % (S.E. 0.9) ranging from 75.3 % to 79.9 %. 
The corresponding amino acid sequence similarities within the cluster were 
92.2 % and 91.6-98.1 % (mean 93.9 %; S.E. 0.9) for clusters A and B, respec-
tively. Between the subclusters, the aa sequence similarities ranged from 89.3 % to 
93.9 % (mean 91.3 % S.E. 1.2). The phylogenetic analysis based on the amino 
acid sequences did not support intra-typic subclustering, which was observed with 
the nucleotide sequences in the VP1 region. 
 
Figure 14. The phylogenetic relationship of the EV-96 strains. The tree was con-
structed from the VP1-coding sequence using the Tamura-Nei model of 
substitution and the Neighbour-Joining method of tree construction. The 
bootstrap support values were calculated for 1000 replicates. 
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5.4.2 Amino acid substitution pattern (V) 
In the VP1 region, 242 out of 309 amino acid sites (78 %) were conserved among 
all of the EV-96 strains (Fig. 15). At 27 of 67 variable sites, mutations unique to 
single strains were observed. In contrast, 14 (4.5 %) amino acid sites showed high 
polymorphism with more than two different amino acid residues observed among 
the strains. 
 
Figure 15. The proportions of conserved and polymorphic amino acid sites among 
the EV-96 strains in the VP1 region. At single mutation sites, amino acid 
substitution was only detected in a single strain, whereas, at highly poly-
morphic sites, more than two different amino acids were detected among 
the strains. 
Only a few of the variable sites corresponded to the subclustering of the EV-96 nt 
phylogeny, i.e., no cluster-specific amino acid signature was observed between 
clusters A and B. The sole exception was site 27 (leucine L vs. isoleucine I). At 
some sites, a distinct amino acid mutation had independently occurred several 
times (as judged by clustering at the nt level) (Fig. 16). For example, at site 91, the 
majority of the strains contain isoleucine, whereas three divergent strains contain 
valin (V). 
The biochemical properties of amino acid side chains (e.g., size, shape, charge, 
hydrogen-bonding capacity and chemical reactivity) determine the folding of a 
protein. Therefore, the aa substitutions that change a property e.g., hydrophobicity 
of a given site are more likely to change the structure of the virus capsid. Alto-
gether, 31 amino acid sites showed substitutions that changed biochemical proper-
ties of the corresponding aa residues. Of these, 13 sites were mutations observed 
in single strains only. None of the mutations were specific for any of the intra-
typic clusters of EV-96. 
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Figure 16. The VP1 aa sites of EV-96 strains that show parallel evolution. The EV-
96 subclusters are indicated with colours: orange (A), green (B1), blue 
(B2). 
5.4.3 Codon-specific selection in the EV-96 VP-1 coding region (V) 
Codon-specific non-synonymous to synonymous substitution frequency ratios 
(dN/dS or Ka/Ks) were assessed using MEGA5 (via HyPhy) and single likelihood 
ancestor counting (SLAC), fixed effects likelihood (FEL) and random effects 
likelihood (REL) methods available at the Datamonkey facility 
(www.datamonkey.org) to detect signatures of selection operating on the VP1 
protein-encoding gene of EV-96. Because synonymous (silent) mutations are ap-
parently neutral (free from natural selection), unless there is codon usage bias, the 
low dN/dS suggests negative (purifying) selection, and the high dN/dS suggests 
positive selection for a given codon. Under neutral evolution the rates of non-
synonymous and synonymous substitutions are expected to be equal. For this 
analysis, the phylogenetic relationships between the EV-96 VP1 gene sequences 
were inferred with the general time reversible (GTR) substitution model and the 
phylogenetic trees were reconstructed by the Neighbour-Joining method. 
This analysis suggested that strong negative selection was occurring over most 
of the codons of the EV-96 VP1-coding region. However, elevated dN to dS ratios 
were detected for some codons by all of the methods, and a subset of methods 
suggested that positive selection was occurring for amino acids at sites 104, 105, 
227, 230 and 295 (Table 8). At these sites, there were strong amino acid polymor-
phism within and between subclusters (Fig. 17). 
 EV-96-05-12
 EV96-05-14
 EV-96-05-10
 EV-96-05517
 EV96-05-2
 EV-96-09228C1
 EV-96-05-05
 EV-96-CAM2083
 EV96-04-7B
 EV96-06-7A
 EV-96-SVK03-24
 EV96-10488
100
100
80
97
100
72
94
93
100
Cluster 5 42 91 94 102 103 117 174 225 227 228 230 233 265 295 298
EV-96-05-12 B2 L S I M V E N N D T T S T V N A
EV96-05-14 B2 L S I I V E N N D T T S T V N T
EV-96-05-10 B2 L S V M T D S N G T T S T V G A
EV-96-05517 B2 L S I I T E N S D T A A T V G A
EV96-05-2 B2 L S I M T E N S D S T S T I N A
EV-96-09228C1 B2 L S V M I E S N G T A G A V N A
EV-96-05-05 B2 I S V M T E N N D T T S T V N T
EV-96-CAM2083 B1 L T I M I E N S D A I S A V G T
EV96-04-7 B1 L S I M T E N T D S T N T V D A
EV96-06-7 B1 L S I M T E N T D N T S A V D T
EV-96-SVK03-24 A I S V M T D N N D D T S A I S T
EV96-10488 A I T I M T A N N D D A A A V N T
Results 
 
THL — Research 87/2012 66 Evolution of New Enterovirus Types EV-94, EV-96 and EV-97 
 
 
Table 8. The EV-96 codons with elevated dN/dS. The statistically significant 
evidence of positive selection is shown in boldface. The significance level 
(p-value/Bayes Factor/posterior probability) of 0.1 or Bayes factor of 50 
(in REL analysis) was used as a confidence limit. Altogether, five 
positively selected and 295 negatively selected sites were detected with 
at least one method. 
 Normalized dN-dS 
Codon HyPhy SLAC FEL REL 
Amino acid composition 
(n of strains) 
104 1.158 0.863 2.514 0.182 A (3), L (1), S (1), M (4), V (1), T(2) 
105 2.110 1.747 3.378 0.253 I (1), A (2), V (1), S (5), T (3) 
227 0.064 0.116 -0.723 0.065 T (6), D (2), A (1), S (2), N (1) 
230 1.309 1.044 0.616 0.966 G (1), A (2), S (8), N (1) 
295 -1.680 -1.410 -2.272 0.990 N (6), G (3), S (1) 
 
Figure 17. The amino acid sites in the VP1 protein that show evidence of positive 
selection. 
5.4.4 Amino acid substitution patterns: a comparison between types (V) 
To compare the evolutionary patterns between enterovirus types and gain insight 
into the origin of new enterovirus types, the VP1 sequences of the EV-96 strains 
were compared to those of their closest relatives, CVA-21, EV-99 and CVA-24. In 
the capsid-coding P1 region these viruses form a subcluster B within the HEV-C 
species (Fig. 10a) and show a hierarchical branching order that corresponds to 
serotype specificity (see above) (Jiang et al., 2007, III). 
The serotypes had within-type minimum amino acid sequence similarities of 
89.3% for EV-96, 90.9 % for CVA-21, 87.7 % for EV-99 and 88.2 % for CVA-24. 
The sequence similarities between types are shown in Table 9. 
 EV-96-05-12
 EV96-05-14
 EV-96-05-10
 EV-96-05517
 EV96-05-2
 EV-96-09228C1
 EV-96-05-05
 EV-96-CAM2083
 EV96-04-7B
 EV96-06-7A
 EV-96-SVK03-24
 EV96-10488
100
100
80
97
100
72
94
93
100
Strain Cluster 104 105 227 230 295
EV-96-05-12 B1 M S T S N
EV96-05-14 B1 M S T S N
EV-96-05-10 B1 V S T S G
EV-96-05517 B1 L A T A G
EV96-05-2 B1 T T S S N
EV-96-09228C1 B1 A I T G N
EV-96-05-05 B1 T T T S N
EV-96-CAM2083 B2 S S A S G
EV96-04-7 B2 A T S N D
EV96-06-7 B2 M A N S D
EV-96-SVK03-24 A A V D S S
EV96-10488 A M S D A N
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Table 9. The ranges of pairwise nucleotide (lower left) and amino acid (upper right) 
similarities between the EV-96, EV-99, CVA-21 and CVA-24 strains. 
 
The consensus alignment of these four enterovirus types contained 309 amino acid 
sites. The aa sites were classified into 5 groups according to pairwise comparisons 
between EV-96 and the other three types: 1) conserved; 2) polymorphic within 
and between types; 3) type-specific conservation (i.e., conserved within type but 
not between types); 4) type-specific polymorphism (i.e., conserved within one 
type but variable within the other type); and 5) insertion / deletion sites (Table 10). 
Table 10. A comparison of the VP1 amino acid sites between EV-96 and CVA-21, 
EV-99 or CVA-24. The consensus alignment contained a total of 309 
amino acids. 
 EV-96 vs. 
 CVA-21 EV-99 CVA-24 
Conserved 174 186 184 
Polymorphic 18 42 42 
Type specific conservation 42 22 18 
Type specific polymorphism 64 (45*) 55 (34*) 61 (44*) 
Insertion/Deletion 11 4 4 
*The sites where amino acid substitution was observed only in a single strand were excluded 
 
The comparison of variable amino acid sites revealed that the polymorphic sites of 
EV-96 and CVA-21, CVA-24 or EV-99 overlap only partially (Fig. 19). In com-
parison to EV-99 or CVA-24, the disparities of the polymorphic sites were subtle 
and often dislocated only by few amino acids, whereas more pronounced differ-
ences were observed in comparison to CVA-21. Respectively, the codons with 
positive selection (detected with the same methods used for EV-96) also over-
lapped only partially (Table 11). Positive selection was detected at codons 104, 
105, 227, 230 and 295 in EV-96; codon 33 in CVA-21; codons 104, 105, 227, 294 
and 296 in EV-99; and codons 29, 104 and 105 in CVA-24. 
When the acute haemorrhagic conjunctivitis-causing variants of CVA-24 
(CVA-24v) were treated as a group separate from the other CVA-24 strains, evi-
dence of positive selection was detected at different sites. For CVA-24v, the only 
positively selected site was 29, whereas, for the other CVA-24 strains, sites 104, 
105 and 294 were under positive selection. Furthermore, several sites that were 
CVA-24 EV-99 CVA-21 EV-96
CVA-24 79.9-87.8 72.1-77.5 72.1-77.0
EV-99 69.4-70.1 72.1-76.2 74.3-78.5
CVA-21 64.0-70.1 64.3-69.8 66.4-70.1
EV-96 63.2-70.2 65.2-69.4 60.9-65.8
Results 
 
THL — Research 87/2012 68 Evolution of New Enterovirus Types EV-94, EV-96 and EV-97 
 
polymorphic in EV-96 and the non-AHC-causing CVA-24 strains were conserved 
in CVA-24v or had polymorphisms only in the earliest isolates. Such sites in-
cluded amino acids 36, 104, 105, 107, 115, 163, 228 and 304 (Fig. 18). 
Many amino acid sites showed a type-specific pattern of conservation (Table 
10). These sites included sites where unique type-specific amino acid conserva-
tions were detected (i.e., sites where a unique amino acid was conserved in one 
EV-type and another amino acid in the other EV-type). 
Substitutions that change the biochemical properties (e.g., hydrophobicity or 
the charge) of a corresponding amino acid residue side chain are more likely to 
change the phenotypic properties (e.g., structure) of the protein. The amino acid 
sites where such changes were observed between EV-96 and CVA-21, CVA-24 or 
EV-99 are summarised in Table 12. 
Table 11. The VP1 amino acid sites with signs of positive selection. The statistically 
significant evidence of positive selection is shown in boldface. The 
significance level (p-value/Bayes Factor/posterior probability) of 0.1 or 
Bayes factor of 50 (in REL analysis) was used as a confidence limit. 
  Normalized dN-dS 
Type Codon HyPhy SLAC FEL REL 
Amino acid composition 
(n of strains) 
CVA-21 33 1.38 3.11 0.55 -0.55 Q (1) 
EV-99 104 -0.03 -0.07 0.36 0.89 Y (2), G (1), T (4), A (9) 
 105 0.47 0.64 4.41 0.97 T (4), A (4), S (7), P (1) 
 227 0.341 0.43 0.41 0.94 V (2), A (8), T (4), D (1),  
S (1) 
 294 0.13 0.10 1.88 0.98 Q (10), S (4), N (1), E (1) 
 296 2.03 2.84 7.83 0.98 T (6), S (5), A (5) 
 304 1.03 1.49 0.71 0.94 S(3), Q(1), N(6), T(4), A(1), 
D(1) 
CVA-24 29 -0.94 -0.09 0.65 -0.41 L (8), H (9), S (1), P (13) 
 104 0.04 0.15 0.22 -0.27 D (20), T (5), E (6) 
 105 -0.27 -0.01 0.36 -0.28 A(24), D(2), Q(2), V(1), 
S(1),T(1) 
 294 0.95 0.62 0.23 -0.30 Q (26), S (4), A (1) 
CVA-24  29 0.17 0.12 -4.41 -1.08 L (7), P (2), H (2) 
(non-AHC) 104 1.60 1.56 0.55 -0.18 D (2), T (5), E (4) 
 105 1.72 1.70 3.57 -0.21 A (4), D(2), Q(2), V(1), S(1), 
T(1) 
 294 1.37 1.31 0.45 -0.20 Q (7), S (4) 
CVA-24v 29 4.41 0.86 7.32 -0.11 P (11), H (7), S (1), L (1) 
 104 -5.36 -1.01 -10.51 -0.96 D (18), E (2) 
 105 0 0 0 -0.84 A (20) 
 294 1.21 0.24 4.08 -0.29 Q (19), A (1) 
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The insertion/deletion sites were at amino acid sites 21-29: CVA-21 had a de-
letion of 9 amino acids, EV-99 had deletion of 5-6 amino acids and CVA-24 had a 
deletion of four amino acids compared to EV-96. Very few conserved amino acids 
were observed between types in this region, whereas only a few singleton amino 
acid substitutions were detected within the types (with the exception of two EV-99 
strains that had an extra amino acid deletion compared to the other EV-99 strains); 
this finding suggests that the insertions/deletions may have occurred independ-
ently for each type. CVA-21 also had a deletion of two amino acids compared to 
EV-96, EV-99 and CVA-24 at amino acid sites 100-101. At this site the other 
three types shared a conserved FN sequence. 
 
Figure 18. The amino acid sites that show evidence of positive selection (circled), or 
polymorphism among the non-AHC-causing strains of CVA-24 but not 
the AHC causing CVA-24v strains 
STRAIN 29 36 103 104 105 107 115 163 228 294 304
CVA-24-Spain4173EV04 P L T D A R A L V Q E
CVA-24- China/GD332/2007 H L T D A R A L V Q E
CVA-24-China/GD391/2007 P L T D A R A L V Q E
CVA-24-China/GD01/2010 P L T D A R A L V Q E
CVA-24-China/GD46/2010 P L T D A R A L V Q E
CVA-24-HG P L T D A R A L V Q E
CVA-24-Spain4186EV04 P L T D A R A L V Q E
CVA-24-Spain4189EV04 P L T D A R A L V Q E
CVA-24-Spain4185EV04 P L T D A R A L V Q E
CVA-24-Spain3961O04 P L T D A R A L V Q E
CVA-24-Spain4183EV04 P L T D A R A L V Q E
CVA-24-Spain4192EV04 P L T D A R A L V Q E
CVA-24-03353/SD/CHN/2003/CA24 P L T D A R A L V A E
CVA-24-Ningbo3-02 P L T D A R A L V Q E
CVA-24-Hangzhou13-02 P L T D A R A L V Q E
CVA-24-DSO-26/2005 H L T D A R A L V Q E
CVA-24-06.278.4269 H L T D A R A L V Q E
CVA-24-SF12Yunnan07 H L T D A R A L V Q E
CVA-24-JAM87-10628 S P T E A K A L V Q E
CVA-24-variant-Japan(EH24/70) L S T E A K A L V Q E
CVA-24-PUR82-10626 P S T T D K P I T Q N
CVA-24-PUR82-10686 P S S T D K P I T Q N
CVA-24-67897 L S T T Q K P I T S N
CVA-24-65902 H S T T V K S I T S E
CVA-24-USA-Tx79-10625 L S S E A K P I T Q D
CVA-24-E34-dn19 L S T E S K P I T Q T
CVA-24-CAM1952 L P S E A K P I T Q D
CVA-24-Joseph L S S E A K P I A S A
CVA-24-09088/SD/CHN/2009/CA24 H S I D T K P I T Q A
CVA-24-99053/SD/CHN/1999/CA24 L S S T Q K P I T S K
CVA-24-05-1 L S T D A K P I T Q N
NO
N-
AH
C 
CA
US
IN
G
VA
RI
AN
T
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Figure 19. The distribution of the VP1 polymorphic amino acid sites in EV-96 com-
pared to CVA-21 (a), EV-99 (b) and CVA-24 (c). The proportion of poly-
morphic strains (compared to the consensus sequence) out of the total 
number of strains in a given type was plotted for each VP1 amino acid 
site. 
-0,8
-0,6
-0,4
-0,2
0
0,2
0,4
0,6
0,8
0
10
0
20
0
30
0
CVA-21
EV-96
-0,8
-0,6
-0,4
-0,2
0
0,2
0,4
0,6
0,8
0
10
0
20
0
30
0
EV-99
EV-96
-0,8
-0,6
-0,4
-0,2
0
0,2
0,4
0,6
0,8
0
10
0
20
0
30
0
CVA-24 
EV-96
0
10
0
20
0
30
0
0
10
0
20
0
30
0
0
10
0
20
0
30
0
a)
b)
c)
Results 
 
THL — Research 87/2012 71 Evolution of New Enterovirus Types EV-94, EV-96 and EV-97 
 
Table 12. The amino acid sites that show differences between types in the 
biochemical properties of amino acid side chains. 
Site Amino acid Amino acid type 
 EV-96 CVA-21 EV-99 CVA-24 EV-96 CVA-21 EV-99 CVA-24 
5 L, I L, F V T Hydro-
phobic 
Hydro-
phobic 
Hydro-
phobic 
Polar 
(hydro-
philic) 
8 T, S T, S K T, A Polar 
(hydro-
philic) 
Polar  
(hydro-
philic) 
Positive, 
highly 
hydro-
philic 
Variable 
32 A Q, S A, S Q, H, R Hydro-
phobic 
Polar  
(hydro-
philic) 
Variable Variable 
80 T C T T Polar 
(hydro-
philic) 
SH- 
(hydro-
phobic) 
Polar 
(hydro-
philic) 
Polar 
(hydro-
philic) 
88 S A S S Polar 
(hydro-
philic) 
Hydro-
phobic 
Polar 
(hydro-
philic) 
Polar  
(hydro-
philic) 
101 A S A A Hydro-
phobic 
Polar  
(hydro-
philic) 
Hydro-
phobic 
Hydro-
phobic 
110 L H Q Q Hydro-
phobic 
Positive 
highly 
hydro-
philic 
Polar Polar 
113 V T, I V T, R Hydro-
phobic 
Variable Hydro-
phobic 
Variable 
115 E, D N P, S P, A Negative 
highly 
hydrophilic 
Polar Variable Variable 
138 T L L, I L Polar 
(hydro-
philic) 
Hydro-
phobic 
Hydro-
phobic 
Hydro-
phobic 
149 Y P Y, F Y, H Hydro-
phobic 
Ring* Hydro-
phobic 
Variable 
155 H E H, Y H, Y Positive 
highly 
hydrophilic 
Negative 
highly 
hydro-
philic 
Variable Variable 
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Table 12. (continued) 
 
Site Amino acid Amino acid type 
 EV-96 CVA-21 EV-99 CVA-24 EV-96 CVA-21 EV-99 CVA-24 
175 A S A, T A Hydro-
phobic 
Polar  
(hydro-
philic) 
Variable Hydro-
phobic 
192 T M T T Polar 
(hydro-
philic) 
Hydro-
phobic 
Polar 
(hydro-
philic) 
Polar 
(hydro-
philic) 
195 C N C, S S, C, T SH-group 
(hydro-
phobic) 
Polar Variable Variable 
198 P P A P Ring* Ring* Hydro-
phobic 
Ring* 
237 Q L L, Q, 
S 
L Polar Hydro-
phobic 
Variable Hydro-
phobic 
238 T V V V Polar 
(hydro-
philic) 
Hydro-
phobic 
Hydro-
phobic 
Hydro-
phobic 
254 H S F F, Y Positive 
highly 
hydrophilic 
Polar  
(hydro-
philic) 
Hydro-
phobic 
Hydro-
phobic 
257 A H, Y A, T A Hydro-
phobic 
Variable Variable Hydro-
phobic 
258 R T A, R R Negative 
highly 
hydrophilic 
Polar  
(hydro-
philic) 
Variable Negative 
highly 
hydro-
philic 
260 T H T T, I Polar  
(hydro-
philic) 
Positive 
highly 
hydro-
philic 
Polar 
(hydro-
philic) 
Variable 
261 S T A S Polar  
(hydro-
philic) 
Polar  
(hydro-
philic) 
Hydro-
phobic 
Polar  
(hydro-
philic) 
274 V C C C Hydro-
phobic 
SH- 
(hydro-
phobic) 
SH- 
(hydro-
phobic) 
SH- (hy-
dropho-
bic) 
284 P L P P, S Ring* Hydro-
phobic 
Ring* Variable 
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Table 12. (continued) 
 
Site Amino acid Amino acid type 
 EV-96 CVA-21 EV-99 CVA-24 EV-96 CVA-21 EV-99 CVA-24 
293 K, T I K, R, 
V 
K, Q, N, 
E 
Variable Hydro-
phobic 
Variable Variable 
296 T, Q, 
S 
A S, A, T S, A, T Variable Hydro-
phobic 
Variable Variable 
302 P K, E P A Ring* Variable Ring* Hydro-
phobic 
304 T, S, 
N, A 
D S, Q, 
N, T, 
A, D 
K, A, D, 
T, E, N 
Variable Negative 
highly 
hydro-
philic 
Variable Variable 
 
*The sidechain of proline has a heterocyclic structure. Proline is often found in the bends of protein 
foldings.  
5.4.5 Directional selection: a comparison between types (V) 
To detect signs of positive selection between EV-96, CVA-21, CVA-24 and EV-
99, the McDonald-Kreitman test (McDonald & Kreitman, 1991) was used. In this 
method the variable nucleotide sites are classified as fixed (F) (i.e., conserved 
within type but not between types) or polymorphic (P) (i.e., variable either in one 
or in both types). The fixed and polymorphic sites are further divided into two 
groups that contain synonymous (s) and nonsynonymous (n) substitutions. In the 
case of neutral evolution, the non-synonymous to synonymous substitution ratios 
should be equal for the fixed and polymorphic sites (i.e., the null hypothesis of the 
test is E(nF)/E(sF) = E(nP)/E(sP) where E stands for expectation operator). The 
proportion of base substitutions fixed by natural selection, α, can be estimated in 
the following way: α = 1-(sF*nP/nF*sP) (Smith & Eyre-Walker, 2002). 
The numbers of sites in each class for different EV-types is shown in Table 13. 
The significance of the difference between the two proportions can be assessed 
with statistical tests (Fisher's exact test shown here). The McDonald-Kreitman test 
showed significantly increased proportion of non-synonymous mutations among 
the fixed sites for inter-typic comparisons, whereas, no deviation from neutrality 
was observed within EV-96 (Table 13). Although the results of the McDonald-
Kreitman test should be interpreted cautiously, since e.g., codon usage bias affects 
the results (Akashi, 1994), the analysis underlines a strong tendency towards the 
fixation of different amino acids when different EV-types are compared. 
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Table 13. The numbers of sites in the McDonald-Kreitman test classes 
(s=synonymous; n=non-synonymous). P-values were calculated with the 
Fisher's exact test. α stands for the proportion of fixed base substitutions. 
  Fixed 
(between groups) 
Polymorphic   
Types compared sF nF sP nP P-
value 
α  
EV-96 (A) EV-96 (B) 18 1 381 48 0.36 -1.268 
EV-96 (B1) EV-96 (B2) 20 3 341 39 0.72 0.238 
EV-96 CVA-21 12 84 448 45 *** 0.986 
EV-96 EV-99 12 43 425 41 *** 0.973 
EV-96 CVA-24 10 42 431 45 *** 0.975 
CVA-21 EV-99 7 50 429 33 *** 0.989 
CVA-21 CVA-24 6 40 439 38 *** 0.987 
EV-99 CVA-24 6 14 415 31 *** 0.968 
*0.01<P<0.05; ***0.001<P<0.01; ***P<0.001 
 
5.4.6 Amino acid substitutions in relation to the three-dimensional 
structure of CVA-21 (V) 
The inter-typic amino acid substitutions between EV-96 and CVA-21 were super-
imposed onto the three-dimensional structure of CVA-21 (Xiao et al., 2005). The 
CVA-21 capsid pentamer structure with amino acid sites classified as indicated in 
Table 10 is shown in Fig. 20. 
Both EV-types have highly polymorphic regions at the buried N-terminal end 
and at sites 102-105, which are located in the exposed BC-loop close to the star-
shaped five-fold axis of the capsid pentamer. Additionally, the insertion/deletion 
sites were located at these regions. 
EV-96 had a highly polymorphic region at sites 225-233 (G-H loop), whereas 
the amino acid sequence of CVA-21 was completely conserved at this region. 
Around this region at sites 223, 224, 234, 237 and 238, a type-specific conserva-
tion of amino acids was observed, which contained I223L, K224E, Y234F, Q237L 
and T238V , respectively, for the EV-96 strains and CVA-21 strains (Fig. 22). For 
CVA-21, these regions (βG and βH strands and the G-H and E-F loops) are among 
the contact regions between ICAM and VP1 (Xiao et al., 2001, Xiao et al., 2005). 
In contrast, amino acid sites at the HI-loop showed polymorphism among the 
CVA-21 strains but not the EV-96 strains. 
Many of the EV-96-specific conservations (i.e., polymorphic sites for CVA-
21) and inter-typic substitutions that change the biochemical properties(e.g., hy-
drophobicity) of the homologous amino acid sites were adjacent to the ‘walls’ of 
the canyon around the star-shaped protrusion at the five-fold axis of the capsid 
pentamer (Fig. 21). 
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Figure 20. The CVA-21 capsid pentamer; top view (left hand panel) and side view 
(right hand panel). The VP1 amino acid residues are shown in colour, 
and VP2-VP4 are shown in grey. The amino acids conserved between 
the types are shown in blue, the type-specific conservations in red, the 
polymorphic sites in both types in yellow, the CVA-21-specific poly-
morphism in white and the EV-96-specific polymorphism in cyan. 
 
Figure 21. The CVA-21 capsid pentamer: top view (left hand panel) and side view 
(right hand panel). The VP1 amino acid residues are shown in colour, 
and VP2-VP4 are shown in grey. The type-specific changes that affect 
the biochemical properties of the amino acid side chains are shown in 
red and the EV-96-specific conservations (polymorphic among CVA-21) 
are shown in orange. 
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Figure 22. The amino acid sequence alignment that corresponds to the G-H loop 
and the βH strand involved in CVA-21 receptor binding. The polymorphic 
sites are indicated in green and the type-specific conservations in red. 
The amino acid sites with evidence of positive selection are circled in 
red. 
C
V
A
-2
1 
am
in
o 
ac
id
 s
ite
20
6
20
7
20
8
20
9
21
0
21
1
21
2
21
3
21
4
21
5
21
6
21
7
21
8
21
9
22
0
22
1
22
2
22
3
22
4
22
5
22
6
22
7
22
8
22
9
23
0
23
1
23
2
23
3
23
4
23
5
23
6
23
7
23
8
23
9
C
on
se
ns
us
 a
m
in
o 
ac
id
 s
ite
21
7
21
8
21
9
22
0
22
1
22
2
22
3
22
4
22
5
22
6
22
7
22
8
22
9
23
0
23
1
23
2
23
3
23
4
23
5
23
6
23
7
23
8
23
9
24
0
24
1
24
2
24
3
24
4
24
5
24
6
24
7
24
8
24
9
25
0
C
V
A
-2
1-
B
A
N
00
-1
04
67
G
F
A
R
V
P
L
E
G
E
N
T
D
A
G
D
T
F
Y
G
L
V
S
I
N
D
F
G
V
L
A
V
R
A
C
V
A
-2
1-
B
A
N
00
-1
05
52
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
B
A
N
00
-1
05
66
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
B
A
N
00
-1
05
42
 
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
G
U
T8
8-
10
61
9 
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
G
U
T8
8-
10
68
7
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
U
S
A
-M
d8
6-
10
63
3
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
99
33
1/
S
D
/C
H
N
/1
99
9/
C
A
21
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
01
13
5/
S
D
/C
H
N
/2
00
1/
C
A
21
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
03
32
7/
S
D
/C
H
N
/2
00
3/
C
A
21
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
99
32
4/
S
D
/C
H
N
/1
99
9/
C
A
21
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
27
25
98
 
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
27
21
01
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
U
S
A
-A
z9
4-
10
62
1
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
27
52
38
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
C
oe
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
U
S
A
-W
a8
9-
10
62
0
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
U
S
A
-M
d8
6-
10
63
3
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
K
uy
ke
nd
al
l
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
U
S
A
-T
x9
6-
10
62
3
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
C
V
A
-2
1-
U
S
A
-G
a9
5-
10
62
2
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
E
V
-9
6-
09
22
8C
1
.
.
.
.
.
.
I
K
.
.
T
A
.
G
.
.
A
Y
.
.
Q
T
.
.
.
.
.
.
A
I
.
L
.
V
E
V
-9
6-
05
51
7
.
.
.
.
.
.
I
K
D
D
T
A
.
.
.
.
.
Y
.
.
Q
T
.
.
.
.
.
.
A
I
.
L
.
V
E
V
-9
6-
S
V
K
03
-2
4
.
.
S
.
.
.
I
K
D
.
D
.
.
S
.
.
A
Y
.
.
Q
T
.
.
.
.
.
.
A
I
.
L
.
V
E
V
-9
6-
C
A
M
20
83
.
.
.
.
.
.
I
K
D
.
A
I
.
S
.
.
A
Y
.
.
Q
T
.
.
.
.
.
.
A
I
.
L
.
V
E
V
96
-1
04
88
.
.
.
.
.
.
I
K
D
.
D
A
.
.
.
.
A
Y
.
.
Q
T
.
.
.
.
.
.
A
I
.
L
.
V
E
V
-9
6-
05
-0
5
.
.
.
.
.
.
I
K
D
.
T
.
.
S
.
.
.
Y
.
.
Q
T
.
.
.
.
.
.
A
I
.
L
.
V
E
V
-9
6-
05
-1
0
.
.
.
.
T
.
I
K
.
.
T
.
.
S
.
.
.
Y
.
.
Q
T
.
.
.
.
.
.
A
I
.
L
.
V
E
V
-9
6-
05
-1
2
.
.
.
.
T
.
I
K
D
.
T
.
.
S
.
.
.
Y
.
.
Q
T
.
.
.
.
.
.
A
I
.
L
.
V
E
V
96
-0
5-
14
.
.
.
.
T
.
I
K
D
.
T
.
.
S
.
.
.
Y
.
.
Q
T
.
.
.
.
.
.
A
I
.
L
.
V
E
V
96
-0
4-
7
.
.
.
.
I
.
I
K
D
.
S
.
.
N
.
.
.
Y
.
.
Q
T
.
.
.
.
.
.
A
I
.
L
.
V
E
V
96
-0
6-
7
.
.
.
.
I
.
I
K
D
.
.
.
.
S
.
.
A
Y
.
.
Q
T
.
.
.
.
.
.
A
I
.
L
.
V
E
V
96
-0
5-
2
.
.
.
.
.
.
I
K
D
.
S
.
.
S
.
.
.
Y
.
.
Q
T
.
.
.
.
.
.
A
I
.
L
.
V
β H
-S
TR
A
N
D
Results 
 
THL — Research 87/2012 77 Evolution of New Enterovirus Types EV-94, EV-96 and EV-97 
 
5.5 Phenotypic properties and evolution: HEV-D as a model 
species (I & IV) 
To elucidate the prevalence, time of emergence and possible target tissues (and 
thus assess the possible clinical symptoms) of new EV-types, the serological and 
biological properties were studied for EV-94 along with other types of the HEV-D 
species. 
HEV-D is the smallest of the enterovirus species and currently contains only 
three types: EV-68, EV-70 and EV-94. Enterovirus 68 was first isolated from 
children with pneumonia and bronchiolitis in California in 1962 (Schieble et al., 
1967) and was later shown to include the strains previously classified as human 
rhinovirus 87 (HRV-87) (Blomqvist et al., 2002, Ishiko et al., 2002). EV-70 was 
first detected in Ghana in 1969 and has since caused acute haemorrhagic conjunc-
tivitis (AHC) pandemics (Mirkovic et al., 1973). Both of these types are also 
capable of infecting the central nervous system (Higgins., 1982, Kreuter et al., 
2011). 
5.5.1 Seroprevalence of HEV-D Types in Finland (I & IV) 
The prevalence of antibodies against the HEV-D types in Finland was assessed 
using the neutralisation assay. Serum samples collected from pregnant women in 
1983 (n = 86), 1993 (n = 99), and 2002 (n = 96) were studied. Neutralising anti-
bodies against EV-68 were found in 100% of the subjects, against EV-70 in 
15.1%, 21.2%, and 13.5% of the subjects and against EV-94 in 79.1%, 79.8%, and 
79.2% of the subjects in the years 1983, 1993, and 2002, respectively (Fig.4 in I, 
Fig.1 in IV). 
The geometric mean end point titres of the sera are shown in Table 1 (in I). The 
serum samples that were studied had significantly higher levels of antibodies 
against EV-68 than against EV-70 or EV-94 in all of the years for which samples 
were studied (Kruskal-Wallis P < 0.01). The mean antibody levels against EV-68 
showed a decreasing temporal trend, whereas the levels against EV-70 and EV-94 
remained constant over the study period (Kruskal-Wallis P < 0.01). 
5.5.2 Route of infection and tissue tropism (I & IV) 
Most enteroviruses use the faecal-oral or respiratory route of transmission. The 
primary site of infection is usually at the mucosal tissue of the respiratory or 
gastrointestinal tract. The primary infection can occasionally be followed by a 
viremic phase. During the viremic phase, the virus spreads through the lymphatic 
system and circulation and may gain access to the secondary target tissues. The 
other HEV-D types, EV-68 and EV-70, differ from most enteroviruses by infect-
ing their primary target tissue (the respiratory tract for EV-68 and the conjunctiva 
for EV-70) directly. The tissue tropism of a virus is a major factor that influences 
the incidence and severity of enterovirus-induced diseases. Therefore, the possible 
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route of infection and tissue tropism for the new HEV-D type, EV-94, were stud-
ied. 
5.5.2.1 Acid sensitivity 
Sensitivity to acid treatment and optimum growth temperature infer the primary 
target tissue and route of transmission of the virus. To access primary replication 
sites in the alimentary channel mucosa, the virus has to pass through the acidic 
environment of the stomach. Rhinoviruses, in general, are sensitive to acid treat-
ment, whereas enteroviruses are not sensitive. However, EV-68 (Blomqvist et al., 
2002) and some strains of EV-70 have been shown to be sensitive to low pH, and 
EV-68 has a lower optimum growing temperature than most other enteroviruses 
(Oberste et al., 2004). 
To assess the possible transmission route of EV-94, the acid sensitivity of EV-
94 was tested using a standard assay (Couch., 1992). Acid treatment did not affect 
the infectivities of the environmental EV-94 isolates (Table 3 in I), whereas the 
titre of the acid-sensitive control, HRV-2, was reduced 10000-fold. The titre of the 
acid-insensitive control, PV1-Sabin, was not affected by acid treatment. 
5.5.2.2 Cell tropism 
To assess the cell tropism and potential secondary target tissues of EV-94, viral 
multiplication and the ability to induce damage in different cell types were studied 
using continuous cell lines and primary cells.  
Consistent with acid stability, EV-94 was able to multiply and induce CPE in 
colon-derived CACO-2 cells. In addition, several other continuous cell lines were 
susceptible to EV-94 infection (Fig. 3 in I). 
During viremia, blood cells may provide enteroviruses with an additional rep-
lication site, thus lengthening the viremia and/or increasing the viral load during 
viremia. The viruses may also spread to secondary target tissues within circulating 
leukocytes that have been infected. Therefore, the susceptibilities of monocytic 
(THP-1, RC-2A, and U937), granulocytic (HL-60 and KG-1), T-cell (MOLT and 
Jurkat), and B-cell (Raji) lineages to EV-94 and EV-68 infections were studied. 
For EV-94, infectious progeny production was detected in all of the studied 
cell lines 24 h post infection (p.i.) (Fig. 2a in IV). The viability of these cell lines 
was reduced significantly 3 days after EV-94 infection (ANOVA, P < 0.005; Fig. 
2b in IV). For EV-68, an increase in viral titre was detected in the T-cell lines 
MOLT and Jurkat, the B-cell line Raji, the granulocytic cell line KG-1, and in the 
monocytic cell line U-937, whereas no definitive infective virus production was 
detected in the monocytic cell line RC-2A or the granulocytic cell line HL-60 
(Fig. 2c in IV). EV-68 infection did not induce statistically significant changes in 
the viability of the leukocytes. 
Replication in the endothelial cell lining of blood vessels may provide a virus 
with an access route to secondary target tissues. EV-94 and EV-70 showed defi-
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nite CPE and progeny production in human umbilical vein-derived endothelial 
cells (Fig. 3a in IV). The infection of endothelial cells was confirmed by the co-
staining of the endothelial cell-specific von Willebrand factor and the virus capsid 
(Fig. 3b in IV). However, there was substantial donor-specific variation in the 
susceptibility of endothelial cells to HEV-D infections. Infective progeny forma-
tion was detected in cells isolated from 12 out of 14 donors after EV-94 infection 
and 7 out of 11 donors after EV-70 infection. A low level of progeny formation 
but no definitive cytopathic effect were detected after EV-68 infection in the cells 
derived from two of the six donors. 
The pancreas is one of the most important secondary target tissues for human 
enteroviruses, and enteroviruses have been considered to play a significant role in 
the etiology of type 1 diabetes (reviewed in Smura & Roivainen 2012; Hober & 
Sane, 2011). The pancreatic islets of three donors were infected with both EV-94 
and EV-68. Viral infection led to the detection of an infectious progeny formation 
for both viruses (Fig. 4a in IV). The viability of the islets was drastically reduced 
4–7 days after infection with EV-94 (n = 4), whereas the mock-infected control 
islets and the islets infected with EV-68 (n = 3) remained viable during the same 
period (Fig. 4b in IV). The co-staining of viral protein and insulin indicated that 
both viruses were able to infect insulin-producing pancreatic β-cells (Fig. 4c in 
IV). To assess the β-cell-specific destruction, the insulin to cellular DNA ratios 
were measured at several time points after infection. The insulin-to-DNA ratio 
decreased significantly 8–14 days after infection with EV-94 (n = 3). There was no 
change in the insulin to DNA ratio after EV-68 infection (n = 2) (Fig. 4d). 
5.5.2.3 Tropism for non-primate cell lines 
Most human enteroviruses have strict host specificity and can infect only human 
or other primate cells. Accordingly, EV-94 induced CPE and showed definite 
infectious progeny production in a wide variety of human and other primate cell 
lines (Fig. 3a in I). However, EV-94 also replicated and induced CPE in a variety 
of non-primate cell lines such as recombinant mouse L cells expressing human 
PVR (L20B) and hamster kidney cells (BHK21) (Fig. 3b in I). Virus replication 
without a strong CPE was found in rabbit kidney cells (RK13). No signs of repli-
cation or altered morphology were found in the mouse embryonic fibroblast cell 
line (3T3). In bovine kidney (MDBK) and canine kidney (MDCK) cells, the virus 
infection altered cell morphology and induced cell death, but no viable virus prog-
eny formation was detected. However, an enterovirus-specific antibody produced 
a positive signal in an immunofluorescence assay in MDBK cells (Fig. 3c in I), 
suggesting that EV-94 is able to internalise into these cells, and there is at least 
limited viral gene expression. No viral proteins were detected in the MDCK cells. 
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5.5.2.4 Receptor usage 
Viral receptor usage is an important determinant of cell/tissue tropism, host range 
and pathogenesis. The role of DAF (CD55), the vitronectin receptor (αvβ3) and 
PVR (CD155) in cell attachment and virus internalisation was studied using CPE 
protection assays (Nobis et al., 1985). The blocking antibodies were not able to 
prevent infection in the RD cells. 
Chinese hamster ovary (CHO) cell lines expressing either the α2 subunit of the 
α2β1 integrin or HCAR and mouse fibroblast (M4) cells expressing intracellular 
adhesion molecule 1 (ICAM-1) were used to assess the role of α2β1, HCAR and 
ICAM-1, respectively, in EV94 infection. Equal amounts of progeny formation 
were found in α2- and HCAR-expressing CHO cells. No progeny virus production 
was found in M4 or M4–ICAM cells, but mild CPE was detected in M4–ICAM 
cells. 
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6 Discussion 
In this thesis, genetic evidence for the classification of three new enterovirus types 
was presented. Further characterisation was conducted for one of the new types, 
enterovirus 94. Sequence analysis methods were used to infer evolutionary rela-
tionships between the new and previously known EV types and possible mecha-
nisms behind the emergence of the new enterovirus clades. 
6.1 New enterovirus types 
The application of molecular typing methods for enterovirus detection has led to 
the discovery of many new enterovirus types (Table 14) (reviewed in Smura et al., 
2011). The enterovirus strains characterised in this thesis formed distinct mono-
phyletic clades within the species HEV-B, HEV-C and HEV-D in their capsid-
coding regions and had less than 75% nucleotide sequence (< 85% amino acid 
sequence) similarities with previously known enteroviruses in their VP1 protein-
coding sequences. These results suggest that these strains represent previously 
unknown enterovirus types and are designated as EV-94 (HEV-D), EV-96 (HEV-
C) and EV-97 (HEV-B). The isolates of the new enterovirus types listed in Table 
14 have been collected in the past six decades and neutralizing antibodies against 
one of the new types, EV-94, were detected from serum samples collected three 
decades ago (I, IV). Furthermore, despite recent discovery, some of the strains 
(e.g., EV-96) have substantial sequence variation suggesting extensive circulation 
before the first detection (II, III). Unfortunately, there are currently not enough 
sequence data to reliably estimate the time of origin for the new enterovirus types 
described in this thesis (i.e., to conduct molecular clock analysis). The discovery 
of these apparently new virus types is most likely due to the application of mo-
lecular typing methods to samples that have remained ‘untypable’ by antigenic 
typing methods, direct sequencing from clinical samples and increased typing 
effort rather than the recent emergence of these viruses in human population. 
Therefore, the mechanisms behind the appearance of a new EV-type most likely 
apply also to previously known EV-types. 
Discussion 
 
THL — Research 87/2012 82 Evolution of New Enterovirus Types EV-94, EV-96 and EV-97 
 
 
Table 14. New (i.e. ‘numbered’) enterovirus types. 
 Host species Year* Country Symptoms Accession 
no. 
Ref. 
HEV-A       
EV-71 Homo sapiens 1969 USA / Ca Encephalitis, 
Aseptic 
menigitis; 
HFMD 
U22521 [1] 
EV-76 H. sapiens 1991 France gastroenteritis  AF697458 [2] 
EV-89 H. sapiens 2000 Bangladesh AFP AF697459 [2] 
EV-90 H. sapiens 1999 Bangladesh AFP AF697460 [2] 
EV-91 H. sapiens 1999 Bangladesh AFP AF697461 [2] 
EV-92 Macaca mulatta, 
M.nemestrina, 
Cercocebus atys 
1999 USA diarrhea EF667344 [3] 
SV-19 M. fascicularis, 
M. mulatta; M. 
nemestrina 
1956   AF326754 [4] 
SV-43 M. fascicularis 1956     AF326761 [4] 
SV-46 M. mulatta, M. 
nemestrina 
NA   AF326764 [5] 
A-13 Papio cyno-
cephalus 
NA    AF326750 [6] 
HEV-B       
EV-69 H. sapiens 1959 Mexico None AY302560 [7] 
EV-73 H. sapiens 1955 USA / Ca NA AF241359 [8] 
EV-74 H. sapiens 1975 USA / Ca Fever, seizures AY556057 [9] 
EV-75  H. sapiens 1974 Ethiopia None AY556065 [9] 
EV-77  H. sapiens 1999 France Meningitis AY208119 [10] 
EV-78 H. sapiens 1999 France Pneumopathy AY208120 [10] 
EV-79  H. sapiens 1979 USA NA AY843297 [11] 
EV-80  H. sapiens 1967 USA NA AY843298 [11] 
EV-81  H. sapiens 1968 USA NA AY843299 [11] 
EV-82  H. sapiens 1974 USA NA AY843300 [11] 
EV-83  H. sapiens 1976 USA NA AY843301 [11] 
EV-84  H. sapiens 2003 Cote 
d’Ivoire 
NA DQ902712 [11] 
EV-85  H. sapiens 2000 Bangladesh AFP AY843303 [11] 
EV-86  H. sapiens 1999 Bangladesh AFP AY843312 [11] 
EV-87  H. sapiens 2001 Bangladesh AFP AY843305 [11] 
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EV-88  H. sapiens 2001 Bangladesh AFP AY843306 [11] 
EV-93 H. sapiens 2000 DRC AFP EF127244 [12] 
EV-97 H. sapiens 1999 Bangladesh AFP AY843307 [11] 
EV-98  H. sapiens   Japan  Gastrointestinal AB426608 [13] 
EV-100 H. sapiens 2000 Bangladesh AFP DQ902713 [11] 
EV-101 H. sapiens 2002 Cote 
d’Ivoire 
NA AY843308 [11] 
EV-107 H. sapiens   Japan  Gastrointestinal AB426609 [13] 
EV-110 Pan troglodytes 2006 Cameroon NA JF416934 [14] 
HEV-C       
EV-96  H. sapiens 1999 Cambodia AFP AB207266  [15] 
EV-99  H. sapiens 1984 USA / Ga NA EF555644 [16] 
EV-102 H. sapiens 1999 Bangladesh AFP EF555645 [16] 
EV-104 H. sapiens 2004-
2007 
Switzerland ARI EU840733 [17] 
EV-109 H. sapiens 2008 Nicaragua ARI GU131227 [18] 
HEV-D       
EV-68 H. sapiens 1962 USA / Ca Pneumonia, 
broncholitis 
AY426531 [19] 
EV-70 H. sapiens 1969 Ghana AHC DQ201177 [20] 
EV-94 H. sapiens 2001 DRC AFP DQ916376  (I) 
EV-111 Pan troglodytes 2006 Cameroon NA JF416935 [14] 
AFP, acute flaccid paralysis 
AHC, acute haemorrhagic conjunctivitis 
ARI, acute respiratory infection 
HFMD, hand, foot and mouth disease 
NA, not available 
*Year of the first known isolate 
 
[1] Schmidt et al (1974) 
[2] Oberste et al (2005) 
[3] Nix et al (2008) 
[4] Hoffert et al (1958) 
[5] Heberling et al (1965) 
[6] Fuentens-Marins et al (1963) 
[7] Rosen et al (1973) 
[8] Oberste et al (2001) 
[9] Oberste et al. (2004) 
[10] Norder et al (2003) 
[11] Oberste et al (2007) 
6.2 How do enteroviruses evolve? 
Multiple interconnected processes can be hypothesised to occur during enterovirus 
evolution. The enterovirus lineages may evolve by gradual diversification (ana-
genesis) and/or more rapid changes such as adaptive radiation (i.e., a rapid in-
crease in sequence diversity due to a single lineage's adaptation to the envi-
ronment) or genetic drift during population bottlenecks. As for evolution in gen-
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eral, the mechanisms for these processes are mutation and recombination, and the 
driving forces are natural selection and genetic drift. 
6.2.1 Different mutation patterns were observed in intra-typic and 
inter-typic comparisons 
 
The data presented in this thesis suggests that the evolutionary process leading to 
the appearance of new enterovirus types may differ from the process behind evo-
lution within intra-typic lineages. The viral VP1-coding sequence of EV-96 was 
analysed along with the other HEV-C types to gain insight into these processes. 
Although the data presented here (as with any sequence data set) are bound to 
represent only a tiny fraction of the actual viral diversity in nature, and the se-
quence analysis methods used are sensitive to such biases, the high intra-typic 
sequence diversities detected suggest that the intra-typic datasets can be con-
sidered representative samples of the respective viral populations despite their 
small size. 
The dataset contained twelve EV-96 strains with relatively high sequence di-
vergences (approaching the < 25 % nt divergence limit for grouping into the same 
type). The phylogenetic analysis (II, III) suggested that all 12 of the strains group 
robustly (i.e., with high bootstrap support) into two major clusters. The larger of 
the clusters (Cluster B) also contained subclusters of more closely related strains. 
Despite robust clustering by nucleotide sequences, no cluster-specific amino 
acid signatures could be detected for EV-96 (with the exception of phylogeneti-
cally very close relatives, which are likely to share similar point mutations by 
genetic drift). These results suggest that the genetic diversity and clustering within 
the EV-96 type is largely due to silent mutations. 
The selection analysis detected strong negative selection at most of the sites 
and relieved negative selection or positive selection at a few highly polymorphic 
sites. This detection may be explained by a selective pressure posed by the host 
immune system to amino acids at the virus surface (e.g., antigenic sites). Muta-
tions at these sites could allow the virus to escape from the host immune response. 
Due to the adaptability of the host immune system, the advantage could be short 
term, because the circulation of the virus in a host population results in an increase 
in the proportion of immune hosts, which changes the ‘direction’ of the selective 
pressure. Consequently, the novelty of the site (for the host population) is most 
likely more important for viral fitness than fixation of a distinct amino acid se-
quence. At the virus population level, this changing selective pressure could result 
in a highly polymorphic site. 
Alternatively, amino acid toggling (i.e., switching between a wild type amino 
acid that is associated with high replicative fitness and susceptibility to the im-
mune response and an escape state with lower replicative fitness) is expected for a 
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class of amino acid sites that mediate escape from host immune system at the cost 
of replicative fitness for the virus (Delport et al., 2008). Toggling has been sug-
gested to occur during, for example, EV-71 circulation (Tee et al., 2010). The 
large number of singleton amino acid mutations among the EV-96 strains suggests 
that deviations from a wild type sequence are continuously produced. Although 
none of the EV-96 VP1 amino acid sites were detected as toggling, parallel amino 
acid substitutions were detected at several sites. Therefore, the failure to detect 
toggling sites may be due to the small sequence dataset.  
These results suggest that the intra-typic evolution of the EV-96 VP1 protein is 
most likely dominated by (mostly neutral) genetic drift combined with selection at 
antigenic sites even though different EV-96 clusters have a significant degree of 
divergence in both nucleotide and amino acid sequences. For most of the codons, 
negative selection was detected, which suggests a strong evolutionary pressure to 
retain the amino acid sequence and, thus, structure of VP1. Intra-typic lineages 
would therefore have similar structural constraints with variation occurring pre-
dominantly at specific sites, including antigenic sites and their proximity, the 
loops between β-sheets and the structurally disordered amino-terminal segment of 
VP1 (as was suggested for polioviruses (Jorba et al., 2008, Kinnunen et al., 
1990)). 
This hypothesis is also supported by the analyses of other enterovirus types. In-
tra-typic sequence comparisons of enteroviruses have revealed generally low non-
synonymous to synonymous substitution frequency ratios (dN/dS or Ka/Ks) 
(Bailly et al., 2009, Jorba et al., 2008, Simmonds, 2006, Suzuki, 2004, Tee et al., 
2010). For polioviruses, almost all of the amino acid sites of the capsid proteins 
were found to be under negative selection, suggesting that the evolution of the 
neutralising antigenic sites had occurred primarily by genetic drift (Jorba et al., 
2008, Suzuki, 2004). For other enteroviruses, positive selection maintaining amino 
acid polymorphism has been detected only at a few distinctive positions presum-
ably at the outer surface of the VP1 capsid proteins of E-30 and EV-71 (Bailly et 
al., 2009, Tee et al., 2010). 
Intra-typic evolution by antigenic drift (i.e., change of antigenic sites) that most 
likely resulted from selection and/or genetic drift at restricted antigenic sites has 
probably occurred also with EV-68, where the majority of amino acid substitu-
tions occur at potentially antigenic VP1 BC- and DE-loops (Meijer et al., 2012). 
This evolution is in line with the declining temporal trend of geometric mean titres 
of neutralising antibodies against the EV-68 prototype strain Fermon (IV). 
In contrast to the intra-typic evolution of EV-96, the inter-typic comparisons 
between EV-96 and its closest relatives CVA-21, EV-99 and CVA-24 suggest that 
mere antigenic changes are not sufficient to explain the differences between the 
EV types. The polymorphic sites and sites that may be evolving under positive 
selection overlap only partially between different EV types. Furthermore, in con-
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trast to the intra-typic comparisons between genetic clusters, the type-specific 
amino acid signature sites can be easily identified. These observations suggest that 
structural changes have occurred during divergent evolution of EV-types in addi-
tion to changes at antigenic sites. A structural change could expose new amino 
acid sites to selective pressure imposed by the host immune system and, on the 
other hand, require fixation at sites where a polymorphism was previously al-
lowed. 
Accordingly, many of the amino acid differences between types may poten-
tially change the structure of the VP1 protein. For example, these substitutions 
include those that change the hydrophobicity of a given amino acid site. Although 
these substitutions can be also detected between strains of a single EV-type, sub-
stitutions within a type are almost uniformly located at highly polymorphic sites 
(and therefore most likely in structurally disordered regions, such as loops be-
tween β-sheets) or found only in a single strain. 
6.2.2 Possible mechanisms for the emergence of new enterovirus types 
The inter-typic comparisons outline the differences between the types but do not 
explain the appearance of the differences (i.e., the origin of serotypes). One possi-
bility is that the divergence between intra-typic lineages gradually increases, and 
current phylogenetic patterns are explained by the extinction of ‘transitional 
forms’ and/or gaps in sequence data. Such transitional forms between enterovirus 
types have not been detected. When the pairwise VP1 sequence similarities be-
tween the EV-strains are plotted, intra-typic and inter-typic similarity values form 
clearly separated groups rather than a continuum between the serotypes (Brown et 
al., 2009, Oberste et al., 1999, Oberste et al., 1999). Furthermore, the observed 
evolutionary pattern of the capsid-coding region with largely negative codon-
specific selection and a few sites under relaxed negative selection or positive se-
lection (maintaining polymorphism) suggests strict constraints for enterovirus 
capsid evolution. 
Such constrictions might be posed by, for example, the structural demands of 
the capsid-coding proteins in which variation might be expected only at specific 
sites. In contrast, the diversity between serotypes is not restricted to individual 
amino acid sites or protein domains but affects the whole capsid-coding region, 
suggesting that the diversification of a serotype has required a profound reorgani-
sation of the capsid proteins (Simmonds, 2006). 
6.2.2.1 Niche changes 
The reorganisation of the capsid structure may be linked to viral adaptation to a 
new ecological niche. In this scenario, intra-typic polymorphism normally occurs 
within the limitations imposed by a given niche (e.g., structural restrictions of the 
capsid, receptor usage, and temperature and acid sensitivity), and the changes 
beyond the ‘accepted’ variation most likely decrease the fitness of a virus. Never-
Discussion 
 
THL — Research 87/2012 87 Evolution of New Enterovirus Types EV-94, EV-96 and EV-97 
 
theless, due to heterogeneous nature of enterovirus populations such fitness de-
creasing mutations are continuously generated. 
The high mutation frequency of RNA viruses provides enormous potential for 
adaptation (Domingo et al., 2008). In this respect, highly prevalent singleton 
amino acid mutations that were detected among the EV-96 strains might be con-
sidered as evolutionary experiments that, on occasion, may enable the colonisation 
of a new environment or adaptation to a changing environment. Most of these 
mutations, however, are not likely to increase the fitness of the virus in a given 
environment and will not become fixed in the virus population. 
Experimental studies suggest that very small changes in the viral capsid pro-
teins may affect viral cell type-specificity, tissue tropism, host species, cytopatho-
genicity, host cell response to infection and the immune response (Al-Hello et al., 
2005, Al-Hello et al., 2009, Arita et al., 2008, Caggana et al., 1993, Cameron-
Wilson et al., 1998, Chua et al., 2008, Cifuente et al., 2011, Colston & Racaniello, 
1995, Halim & Ramsingh, 2000, Kim & Racaniello, 2007, Knowlton et al., 1996, 
Pan et al., 2011, Pelletier et al., 1998, Polacek et al., 2005, Ramsingh & Collins, 
1995, Ramsingh et al., 1997, Schmidtke et al., 2000). Changes like these are well 
within the reach of rapidly mutating RNA viruses. In this scenario, a viral sub-
population with an altered phenotype (e.g., receptor binding affinity, receptor 
usage, a new co-receptor, an alternative receptor, evasion of the host immune 
system, cell/tissue tropism, host cell replication/translation machinery usage, etc.) 
might be able to occupy a new niche. A new niche would likely have different 
selection pressures (different fitness or adaptive landscape) than the previous 
niche, forcing further mutations to increase fitness. Furthermore, the occupation of 
a new niche would present a population bottle-neck, where some mutations would 
most likely become fixed by chance. The transitional (low fitness) forms would be 
quickly outcompeted and extinct (and most likely not detected). Consequently, the 
adaptation of the virus to the new niche would be detected as an emergence of a 
new virus type. 
A single mutation may also have a pleiotropic effect on virus functions (i.e. af-
fecting many functions). Accordingly, there is evidence of coevolution of cell 
recognition and antigenicity in picornaviruses (Baranowski et al., 2001). For many 
viruses, there is an overlap between receptor binding sites and antigenic sites. For 
example, the residues of the poliovirus antigenic sites influence viral receptor 
recognition (Harber et al., 1995, Murray et al., 1988). Thus, antibody-directed 
selection might indirectly affect the evolution of receptor tropism, and vice versa.  
Intriguingly, several type-specific amino acid differences between EV-96 and 
CVA-21 mapped close to the known receptor interaction sites, suggesting that 
altered receptor binding may have been involved in the divergent evolution of 
these types. The receptor usage of EV-96 has not been studied, but CVA-21 shares 
the ICAM-1 binding property with many of the other HEV-C types, including 
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CVA-13, CVA-15, CVA-18 and CVA-20 (Newcombe et al., 2003). However, 
ICAM-1-binding HEV-C types also have significant differences in cell attachment 
because, despite a common receptor usage, amino acid residues that represent the 
ICAM-1 footprint are not conserved among these types (Newcombe et al., 2003). 
Furthermore, there are apparent differences in co-receptor usage because CVA-21 
also uses DAF for attachment and membrane concentration (Newcombe et al., 
2004, Shafren et al., 1997), whereas CVA-13 binds to an unidentified co-receptor, 
and CVA-20 uses an unidentified internalisation receptor (Newcombe et al., 
2003). These differences suggest considerable plasticity in the receptor/co-
receptor usage of HEV-C viruses – another feature prompting adaptation. In addi-
tion to receptor binding, the large differences in the N-terminal region of VP1 
between EV-96 and CVA-21 suggest that subsequent events in viral uncoating 
(such as extrusion of the N-terminus of VP1 and the release of VP4 (Couderc et 
al., 1993, Moss & Racaniello, 1991)) may be different between these enterovirus 
types. 
CVA-24, a close relative of EV-96, provides an example of evolution through 
adaptation to a new target tissue. The AHC-causing variant of CVA-24 (CVA-
24v) that emerged in 1970 in Singapore (Lim., 1973) forms a subcluster within the 
CVA-24 group (Fig. 23). The phylogenetic analyses suggest a single origin for all 
of the AHC-causing variants (Fig. 23) (Brown et al., 2009). Antigenically CVA-24 
variants are considered to be prime strains of CVA-24 (i.e., the CVA-24v strains 
are poorly neutralised by the antiserum that neutralises the prototype strain, but the 
antiserum made against the variant strains are able to neutralise the isolate and the 
prototype) (Brown et al., 2009, Mirkovic et al., 1974). CVA-24v uses sialic acid as 
a receptor (Nilsson et al., 2008), but the receptor for the non-AHC-causing CVA-
24 strains is not known. Remarkably, another AHC-causing enterovirus type, EV-
70, uses the same receptor (Alexander & Dimock., 2002, Nokhbeh et al., 2005). 
Thus, a receptor switch (possibly) from ICAM-1 to sialic acid might have changed 
the tissue tropism of the ancestor of CVA-24v from the gastro-intestinal tract to 
conjunctiva and therefore enabled the virus to occupy a new niche. 
Despite a considerable amount of conservation in the nucleotide and amino 
acid sequences, different evolutionary processes may be operating for CVA-24v 
and the non-AHC-causing CVA-24 strains at several sites. Intriguingly, the sites 
under positive selection appear to differ between CVA-24v and other CVA-24 
strains. For example, at sites 105 and 304, strong polymorphism was detected for 
the non-AHC causing CVA-24 strains, whereas the CVA-24v strains showed 
complete conservation at these sites. At some sites (e.g., 36, 104, 107 and 254), 
the earliest sequenced isolates of CVA-24v resembled the non-AHC causing 
CVA-24 strains, whereas the fixation of a different amino acid apparently occur-
red thereafter at the CVA-24v lineage. These results suggest that CVA-24v might 
still be under ongoing adaptation, ultimately leading to a new EV type. Accord-
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ingly, the phylogenetic analyses suggest a ladder-like tree with a chronological 
trend for CVA-24v (Chu et al., 2009). Alternatively, some of the amino acid fix-
ations among the CVA-24v strains might be due to genetic drift during the pres-
umably tight population bottle-neck experienced by the first CVA-24 strain capa-
ble of infecting conjunctiva. 
The different CVA-24v lineages can be efficiently separated by the nonstruc-
tural protein-coding sequences (Chu et al., 2009), suggesting that AHC-causing 
variants of CVA-24 do not recombine with other EVs, which is possibly due to 
different cell tropism. Due to the recombination barrier, the AHC-causing variants 
of CVA-24 are likely to evolve independently of other CVA-24 strains either by 
genetic drift or adaptive evolution. 
 
Figure 23. A phylogenetic tree showing clustering of the CVA-24 AHC-causing vari-
ants (CVA-24v) and the non-AHC causing CVA-24 strains. The tree was 
constructed from the P1 coding sequences using the Neighbour-Joining 
method of tree construction. The genetic distances were computed using 
the Tamura-Nei model for nucleotide substitutions. The bootstrap support 
values were calculated for 1000 replicates. 
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6.2.2.2 Inter-species transmission 
Another way to change niches is spreading from one host species to another. Re-
cent studies (Harvala et al., 2011, Harvala et al., 2012, Oberste et al., 2005) have 
suggested that several enterovirus types that represent three of the four known 
HEV species (HEV-A, HEV-B and HEV-D) can circulate in various non-human 
primate species. 
It has also been speculated that Enterovirus 70 (EV-70), a member of the HEV-
D species, might have a zoonotic origin. EV-70 was discovered in Ghana in 1969 
during an acute haemorrhagic conjunctivitis epidemic (Mirkovic et al., 1973) and 
has subsequently caused large-scale epidemics around the world. It has been esti-
mated that all EV-70 isolates have a common ancestor that emerged in one lo-
cation in 1967±15 months (Miyamura et al., 1986, Takeda et al., 1994). Among 
the enteroviruses, EV-70 has an unusually wide host range in vitro. EV-70 is able 
to replicate in cells derived from a wide range of mammalian species (Yoshii et 
al., 1977), and neutralising antibodies against EV-70 have been detected in the 
sera of cattle, sheep, swine, chickens, goats, dogs and monkeys (Kono et al., 1981, 
Sasagawa et al., 1982). However, EV-70 isolates have not been found in animals, 
and the presence of neutralising antibodies against EV-70 in animals might be due 
to an antigenic cross-reaction between EV-70 and some (unknown) animal virus. 
Similar to EV-70, EV-94 shows an unusually wide cell tropism in vitro (I, IV), 
suggesting that it might also be capable for cross-species transmission. A recent 
seroprevalence study revealed that, in addition to European human populations (I, 
IV), a high prevalence of antibodies against EV-94 is present in the human popu-
lations of sub-Saharan Africa (85 %, 68 % and 80 % in Cameroon, Zimbabwe and 
South Africa, respectively), whereas lower seroprevalences were detected among 
chimpanzees and various Old World monkeys (13 % and 2 %, respectively) (Har-
vala et al., 2012). Although the primary host species for EV-94 seems to be hu-
man, these results suggest that non-human primate populations are also exposed to 
this enterovirus type. Intriguingly, in the same study, high prevalences of anti-
bodies against E-11 and EV-76 were found among chimpanzees, gorillas and vari-
ous Old World monkeys providing evidence for inter-species exposure to human 
enteroviruses (Harvala et al., 2012). 
The HEV-D serotypes have other features unusual to enteroviruses. EV-68 and 
some strains of EV-70 are acid labile (Blomqvist et al., 2002, Oberste et al., 2004), 
whereas EV-94 is acid stable similar to other enterovirus serotypes (I). EV-68 is 
also temperature sensitive. These features most likely reflect the tissue tropism of 
these viruses. EV-68 (including strains previously classified as HRV-87) is a res-
piratory tract pathogen (Blomqvist et al., 2002, Ishiko et al., 2002, Oberste et al., 
2004, Schieble et al., 1967), and the primary infection site of EV-70 is at conjunc-
tival cells (Mirkovic et al., 1973). Both of these viruses can occasionally infect the 
central nervous system (Higgins., 1982, Kreuter et al., 2011). EV-94, on the other 
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hand, has been isolated from the stool samples of patients with acute flaccid pa-
ralysis (I) (Junttila et al., 2007) and is able to replicate in various potential target 
cells in vitro including neuroblasts, leukocytes, endothelial cells and pancreatic 
islets (I, IV). EV-94 most likely uses the faecal-oral route of transmission (I), 
whereas EV-68 and EV-70 are transmitted primarily via direct or indirect contact 
with respiratory, oropharyngeal or conjunctival secretions (Pallansch & Roos., 
2001). 
The unique features of the HEV-D types pose a question about the origin of 
this species. If EV-70 emerged from an animal host, where did EV-68 and EV-94 
emerge from? EV-68 was first isolated 5 years prior to the estimated emergence 
time of EV-70. EV-94 was discovered recently, but the serological studies (I, IV) 
suggest that this virus has been circulating at least since the 1980s. Relatively high 
genetic divergences and a lack of recombination between the three HEV-D sero-
types suggest an independent evolution of these viruses, and the divergence of 
these three types from their common ancestor most likely occurred long before the 
detection of the first isolates. If EV-70 indeed emerged from an animal host, EV-
68 and EV-94 either emerged independently from an animal host or, alternatively, 
the members of HEV-D species circulate in multiple host species. 
Recently, a fourth HEV-D type (EV-111) was discovered in the wild chimpan-
zee population in Cameroon (Harvala et al., 2011). Intriguingly, this type appar-
ently circulates in both chimpanzee and human populations. The chimpanzee-
derived strain bears substantial similarity to a HEV-D strain (previously classified 
as EV-70) isolated from a stool sample from a child with AFP in the Democratic 
Republic of Congo (Harvala et al., 2011, Junttila et al., 2007). EV-111 clusters 
with EV-70 in the VP1 region and EV-94 in the 5’UTR and 3D region. These 
phylogenetic inconsistencies suggest that EV-70 and EV-111 share a common 
ancestor in the capsid-coding region, whereas, in the other genomic regions, EV-
94 and EV-111 may have recombined. Notably, the complete genome analysis (I) 
provided no evidence for recombination between EV-68, EV-70 and EV-94. The 
ancestor of EV-111 and EV-70 may have been a gastrointestinal pathogen, and 
(analogous to CVA-24 and CVA-24v) the change of tissue tropism from intestinal 
mucosa to conjunctiva created a recombination barrier between EV-70 and EV-
111/EV-94 and promoted divergent evolution of EV-111 and EV-70. 
6.2.2.3 Inter-species transmission & Capsid-coding sequence evolution 
CBV-5/Swine vesicular disease virus (SVDV) provides an example of capsid-
coding sequence evolution during the adaptation process following host species 
switching. SVDV originated from CBV-5 as the virus spread from humans to pigs 
(Brown et al., 1973, Graves., 1973, Zhang et al., 1993, Zhang et al., 1999) with an 
estimated inter-species transfer time between 1945 and 1965 (Zhang et al., 1999). 
The Bayesian evolutionary analysis of the VP1-coding region suggested that, 
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among the CBV-5 lineages, the evolutionary rate has been highest for the branch 
leading to the most recent SVDV lineages (Gullberg et al., 2010). 
Both CBV-5 and the older SVDV strains (isolated in the 1950s and 1960s) use 
the coxsackie-adenovirus receptor (CAR) as a primary receptor and are able to use 
human decay-accelerating factor (DAF) as a co-receptor (Bergelson et al., 1997, 
Martino et al., 2000). However, CBV-5 does not bind to pig DAF but infects por-
cine cells via pig CAR (Spiller et al., 2002). The more recent SVDV strains (iso-
lated in the 1990s) have lost their ability to bind human DAF and instead use 
heparin sulphate for attachment in porcine epithelial cells (Escribano-Romero et 
al., 2004, Jimenez-Clavero et al., 2005). The comparative structural and amino 
acid sequence studies of CBV-5 and SVDV capsids suggest that adaptation to a 
new host species has induced changes in the CAR-binding site (partially overlap-
ping the putative DAF binding site), the putative heparan sulphate-binding site, the 
antigenic sites, the VP1 hydrophobic pocket and around the five-fold axis of the 
capsid (Fry et al., 2003, Verdaguer et al., 2003). Some of the more recent SVDV 
strains also contain block deletions in the 5’NCR between the end of IRES and the 
translation initiation site (Shaw et al., 2005). 
The apparent similarity in the changes occurring during the adaptation of CBV-
5 to a new host species to those that have occurred during the divergent evolution 
of EV-96 and CVA-21 (i.e., changes in receptor binding sites, putative antigenic 
sites and around the five-fold axis of the capsid) suggests similar changes in selec-
tive pressures during the colonisation of a novel niche and formation of two dis-
tinct enterovirus types from a common ancestor. However, despite the rapid 
colonization of a new niche (similar to CVA-24v), SVDV is not (yet) divergent 
enough to merit classification into a new enterovirus type. Furthermore, separation 
of CVA-24v and SVDV into new types would leave CVB-5 and CVA-24 as para-
phyletic clades. This scenario suggests that either adaptation to a new niche does 
not inevitably lead to the formation of a new type, or alternatively, the process 
may take a relatively long time. Nevertheless, the formation of a new enterovirus 
type may involve a selection period during which adaptive mutations are fixed and 
a more neutral period during which polymorphism increases. 
6.2.2.4 The role of recombination in adaptation to a new niche 
The host species most likely has a significant influence also on the evolution of 
viral non-capsid sequences due to specific interactions between host and viral 
proteins or host proteins and viral RNA (Oberste et al., 2007). The phylogenetic 
analysis of the 5’UTR region (II) provides insight into evolutionary processes that 
may also be involved in the inter-species transmission of viruses. In this region, 
human enteroviruses are grouped into three clusters: one cluster consists of the 
‘old’ HEV-C and HEV-D types, another cluster consists of HEV-A and HEV-B 
types and the third cluster consists of two recently described HEV-C types, EV-
104 and EV-109. This clustering suggests that at least two inter-species recombi-
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nation events have occurred: one between the ancestors of the HEV-A and HEV-B 
species and another between the ancestors of the HEV-C and HEV-D species 
(Santti et al., 1999). Between the modern HEV strains, however, inter-species 
recombination seems to occur only rarely (Smura et al manuscript). 
In addition to human enteroviruses the HEV-A species contains viruses (SV-
19, SV-43, SV-46, BaEV and EV-92,) that infect other primates (Macaca mulatta, 
M. nemestrina, M. fascicularis, Cercocebus atys and Papio cynocephalus) (Ober-
ste et al., 2002, Oberste et al., 2007, Oberste et al., 2008). In phylogenetic trees the 
5’UTRs of these virus types do not cluster together with those of the HEV-A types 
that infect humans but form several outgroups to the HEV-A/HEV-B cluster (II). 
However, in the capsid-coding region, the currently known simian HEV-A types 
cluster together with the recently described HEV-A serotypes that infect humans, 
EV-76, EV-89, EV-90 and EV-91. These results suggest that inter-species trans-
mission occurs from humans to other primates or vice versa. Correspondingly, an 
EV-76 strain was recently detected from a stool sample collected from the wild 
chimpanzee population in Cameroon (Harvala et al., 2011). 
The 5’UTR sequences of EV-76 and EV-89 group together with the HEV-
A/HEV-B cluster, whereas those of EV-90 and EV-91 group together with the 
HEV-C/HEV-D cluster (II). These results suggest that an inter-species recombina-
tion event occurred between the ancestor of EV-90/EV-91 and a member of the 
HEV-C or HEV-D species. Because the 5’UTR contains IRES secondary struc-
tures that bind to host cell-specific translation factors, this region may be espe-
cially important for the colonisation of a new host species. Therefore, the inter-
species recombination event between EV-90/EV-91 and a HEV-C/HEV-D strain 
may be an adaptation to a new host species (i.e., humans). A shift from the ‘mon-
key-specific 5’UTR’ to the ‘human-specific 5’UTR’ may have provided the re-
combinant virus with a selection advantage over the original virus. Correspond-
ingly, the ancestor of EV-76/EV-89 may have recombined with a member of 
HEV-A or HEV-B in the 5’UTR or alternatively gained mutations convergent to 
those in the HEV-A/HEV-B cluster (II). 
In experimental settings, inter-species 5’UTR recombinants are generally via-
ble (Gromeier et al., 1996, Rohll et al., 1994, Schibler et al., 2012, Todd et al., 
1997) but often have lower fitness than the parental viruses (Schibler et al., 2012). 
It is likely, therefore, that inter-species recombinants are able to outcompete the 
parental virus only when the parental virus has low fitness in the given host cell – 
a situation which can be expected to occur during host species switching. 
Curiously, EV-76 and EV-89 form an outgroup to the HEV-A/HEV-B 5’UTR 
cluster (II) and EV-76, EV-89, EV-90 and EV-91 form a distinct group in the non-
structural protein-coding regions (P2 and P3) of the genome, indicating recombi-
nation within this group of novel HEV-A types but not between this group and 
other HEV-A viruses (Oberste et al., 2005). These results suggest that EV-76, EV-
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89, EV-90 and EV-91 might occupy a unique ecological niche, forming a recom-
bination barrier between the ‘new’ and ‘old’ HEV-A types. 
Inter-species recombination (or extensive evolution independent of enterovir-
uses that infect humans) may have also occurred with the Baboon enterovirus 
(BaEV), which clusters together with the HEV-A strains in the P1 region only and 
is not closely related to the HEV-A viruses when other genomic regions are ana-
lysed (Oberste et al., 2007). In this case the inter-species recombination may have 
been an adaptation for replication in baboon cells. 
6.3 The role of recombination in enterovirus evolution 
Enteroviruses, in general, have high rates of recombination within and between 
types (Simmonds & Welch, 2006, reviewed in Lukashev, 2005). As discussed 
above, recombination may aid virus adaptation to new or changing environments 
by providing large genome segments that are possibly pre-adapted to the new 
niche. Furthermore, recombination may permit the elimination of harmful muta-
tions (see the paragraphs on Muller’s ratchet in the Introduction, page 29) or adop-
tion of advantageous traits. Accordingly, recombination events often precede the 
emergence of novel EV lineages (McWilliam Leitch et al., 2009, McWilliam 
Leitch et al., 2010, McWilliam Leitch et al., 2012, Mirand et al., 2007, van der 
Sanden et al., 2011). However, it has proven difficult to demonstrate the benefits 
of recombination experimentally (Pliaka et al., 2010, Savolainen-Kopra et al., 
2009a, Schibler et al., 2012). 
The frequency of inter-typic recombination differs between HEV species: the 
frequency is the highest within the HEV-B species and lower within the HEV-A 
and HEV-C species (Simmonds & Welch, 2006). Within the HEV-D species, no 
evidence of inter-typic recombination was detected (I). However, minor inconsis-
tencies in the clustering pattern of EV-111 in the VP1, 5’UTR and 3D suggest that 
recombination may have occurred between EV-94 and EV-111 (Harvala et al., 
2011). These results suggest that the impact and constraints for recombination 
may differ between EV species and types. 
Several factors restrict recombination. These factors include viral prevalence 
and cell tropism, sufficient nucleotide similarity, co-operation of cis-acting ele-
ments within the genome, the functionality of the resulting chimeric proteins and 
the co-operation of mature proteins. The co-infection of a certain cell is a pre-
requisite for recombination, and different tissue tropism might efficiently restrict 
recombination. As discussed above, these restrictions might occur between mem-
bers of the HEV-D species, because the three serotypes of this species have differ-
ent primary replication sites and cell tropism (I, IV). Similarly, there seems to be a 
recombination barrier between the conjunctiva tropic CVA-24v and other HEV-C 
strains. Furthermore, the CVA-21 strains that have a propensity to cause respira-
tory tract infections tend to cluster together at P2 (Fig. 8b) and the 5’UTR (Smura 
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et al., manuscript). However, in the case of CVA-21, the recombination barrier is 
incomplete, because not all of the strains cluster together in the P3 region (Fig. 
8c), suggesting infrequent and possibly ancient recombination events between 
CVA-21 and other HEV-C types. 
Sequence similarity-derived restrictions for recombination may be exemplified 
by the clustering pattern of the HEV-C strains (III, V). The clustering pattern sug-
gests frequent inter-typic recombination at the 3’ end of the genome. However, the 
detected recombination events become less frequent towards the 5’ end of the 
genome because, in the P2 region, recombination was detected mainly between the 
strains that are closely related in the P1 region. These strains formed a clustering 
pattern where deep nodes of the tree were generally congruent to those of the P1 
tree (with the exception of CVA-13/18 and some EV-96 strains), but more recent 
type-specific nodes were not. At the 5’UTR, however, the P1-specific clustering 
breaks down again. A similar trend can be observed in the recombination history 
of EV-97: promiscuous recombination occurred at the 3’ end of the genome, but 
no recombination partners were found for the majority of the P2 sequence. 
With no assumptions about the mechanism or preferred sites of recombination, 
the probability of a recombination event should increase with the genomic linkage 
distance, i.e., the genomic sites that are physically close to one another are likely 
to be inherited together. This scenario would propose gradually increasing recom-
bination frequency from P1 towards the 5’ and 3’ends of the genome. 
Because homologous recombination requires substantial sequence similarity 
between recombination partners (Worobey & Holmes, 1999), recombination is 
expected to be more common between close relatives and become gradually less 
common with more divergent strains. Furthermore, if nucleotide similarity in-
creases recombination frequency, a positive feedback effect, where a recombina-
tion event increases the probability of further recombinations, would be expected. 
The clustering pattern of the HEV-C strains in different regions of the genome 
suggests that another force is affecting recombination frequencies. With the HEV-
C strains, recombination occurs preferentially within the major clusters, but ge-
netic distance appears not to have a strong effect within major clusters. This scen-
ario would result in a stepwise increase in the frequency of recombination reflect-
ing virus phylogeny. 
The combined effects of linkage, sequence similarity and phylogeny in addi-
tion to the pre-requisition of similar cell tropism may explain the observed recom-
bination pattern with preferred recombination partners. In this scenario, the con-
cordance of the deep (ancient) nodes of P1 and P2 trees would be a result of pre-
ferred recombination within the clade. The two exceptions to major phylogenetic 
clusters (A-C) in the P2 region, CVA-13 and EV-96, suggest that the phylogeny 
barrier can be crossed (i.e., there is no strict incompatibility between the P1 and P2 
regions of cluster A, B and C). Apparently, crossing the barrier occurs infre-
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quently because CVA-13 and EV-96 remain as separate clusters (with further 
subclustering) within clusters A and B at the P2 region, suggesting that the recom-
bination event is most likely ancient. In the P3 region, the linkage effect would 
partly outweight the similarity and phylogeny effects, resulting in an increase in 
observed phylogeny violations towards the 3’ end of the genome. The 5’UTR does 
not show signs of the linkage effect (the 5’UTR is physically close to the P1 re-
gion, but there is no similarity to the P1 grouping). However, this region is highly 
conserved and provides enough sequence similarity for frequent recombination. 
Therefore this region is functioning as a ‘recombination hot spot’, where recombi-
nation events occur at a higher frequency than at other regions. 
Altogether, the phylogenetic pattern of the HEV-C strains suggests non-
random recombination between strains of the same species. Therefore, the fre-
quency of recombination appears to differ between species (Simmonds & Welch, 
2006), types and intra-species groupings, which is possibly due to cell tropism, 
sequence similarity and the phylogenetic position of a given virus strain. 
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7 Concluding remarks and future 
prospects 
A large number of novel enterovirus types have been characterised during the past 
decade, raising a question about the origin of the new viruses. In this thesis, three 
new enterovirus types were established by sequence properties, and one of the new 
types (EV-94) was subjected to further characterisation of phenotypic properties. 
Furthermore, genetic evidence of the general patterns of enterovirus evolution, 
which ultimately leads to the emergence of new virus types, was presented. 
The discovery of many new enterovirus types reflects the application of mo-
lecular typing methods and an increased typing effort rather than the recent emer-
gence of these viruses in the human population. Almost all of the proposed new 
types are characterised only by sequence; hardly anything is known about the 
biology of the proposed new types (e.g., receptor usage, tissue/cell tropism, host 
responses, disease associations and epidemiology). Some of the new serotypes 
(including EV-96 and EV-97) have been detected several times during the last few 
years, suggesting high prevalence and wide geographic circulation. For the others, 
not enough data exists to draw conclusions about the prevalence and epidemiology 
of the virus. The sample types, clinical associations and geographical origins of 
the proposed new types show similarity to the previously established serotypes 
i.e., there seem to be respiratory and gastrointestinal pathogens among the new 
enterovirus types, and many of the types may be capable of causing neurological 
symptoms. 
The sequence analysis presented in this thesis suggests different modes of evo-
lution within enterovirus types (resulting in intra-typic lineages) and during evolu-
tion, which leads to larger scale (type-specific) differences. In this respect, intra-
typic genetic change would be dominated by silent mutations accompanied by 
amino acid polymorphism occurring dominantly at immunogenic sites. This ge-
netic change can be observed as a high rate of synonymous mutations, strong 
negative selection and amino acid polymorphism and/or positive selection at dis-
tinct sites in structurally disordered regions. Inter-typic differences, on the other 
hand, are most likely accompanied by structural alterations in capsid proteins, 
which cause changes in the pattern of the conserved and polymorphic amino acid 
sites and could be a result of adaption to larger scale changes in the environment. 
Intra-typic variation would therefore occur in a restricted sequence ‘space’ that 
retains the capsid structure. On occasion, a novel variant could, however, jump 
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from one sequence space (or fitness landscape) to another, manifesting itself as an 
emergence of a new EV-type. 
The observations described above suggest that a taxonomical level equivalent 
to serotype (or enterovirus type) is still useful even though historically a ’serotype’ 
was defined by antigenic characteristics of a virus and molecular methods have 
surrogated the neutralization tests. The differences between types are not solely 
the ones at antigenic sites. Instead, these differences reflect more profound struc-
tural changes between the serotypes (and therefore the antigenicity or serotype of 
a virus merely reflects more profound differences between viruses). Thus, it ap-
pears that the antigenic properties and the phylogenetic position (i.e., the serotype 
or the type) of each enterovirus reflect a specific ecological niche and/or other 
profound differences in the viral structure. Therefore, the empirical limits (the 
‘75/85 % rule’) for enterovirus typing seem to have a solid evolutionary and bio-
logical basis. 
Altogether, these observations suggest that both adaptation and immunoselec-
tion (combined with structural changes) may be required for the formation of a 
new type. Furthermore, there is no need to assume that similar processes are be-
hind the formation of each new EV-type because the events that predispose the 
formation of a new type are stochastic (and viruses are opportunistic). Recombina-
tion most likely has a dual role in this process by providing gene flow between 
viruses with similar cell tropism and enough sequence similarity (therefore ho-
mogenising the virus population) and creating new combinations of genetic traits. 
Therefore recombination increases the plasticity of a virus population and possibly 
facilitates adaptation to new niches by providing genes pre-adapted to a certain 
niche. 
Evolutionary inferences are dependent on the amount of reliable sequence data. 
However, in respect of enteroviruses, sequence data have accumulated for a rela-
tively short period. In addition, there are both geographical and clinical sampling 
biases, which hamper the evolutionary analyses. As more sensitive detection 
methods that do not require virus culture in cells and/or previous knowledge about 
viral sequence become more widely used and previously understudied sample 
types (e.g., environmental samples or archived samples) are studied, previously 
unknown picornavirus types, species and genera will be characterised in humans 
and other animals. This is likely to revolutionise enterovirus taxonomy and deepen 
our understanding of enterovirus evolution. Furthermore, a more thorough under-
standing of population dynamics, epidemiology and pathogenesis of enteroviruses 
can be established. 
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